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It may be asked why the author of this thesis 
decided to venture into a study of 'Hepatitis B Antigen 
and its Antibodies' when it was obvious that this subject 
was, and would continue to be, the centre of the 
endeavours of established research workers from so many 
scientific disciplines all over the world, but there were 
several sets of circumstances that set the scene for this 
investigation. 
In the first place there was an active team of 
research workers in Groote Schuur Hospital focussing their 
attention on liver disease and in particular on hepatitis. 
Their approach to the treatment of patients in acute 
hepatic failure had caught the attention of a wide 
international audience, and stimulated collateral research 
in other departments at the Medical School. 
In the second place the author was introduced to the 
M.R.C. Virus Research Unit where he found an opportunity for 
analytical studies on new or incompletely characterized virus 
particles. There was a strong bias in this Unit for bio-
physical, biochemical and serological measurements, with a 
host of techniques available which had proved to be 
successful in the study of a number of animal, plant and 
insect viruses. Another important factor was the presence 
of a superb electron microscopy facility. 
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Lastly, but important in the present context, the 
Virus Research Unit had a significant record of fundamental 
research in the field of vaccines and immune sera with 
particular reference to preparative techniques. Vaccines 
and antisera were just beginning to be talked about for 
hepatitis B virus infections when the present study was 
about to start, but long before the logistics of 
immunization programmes could be considered, a great deal 
had to be learned about the virus and its properties. 
Every bit of information however small, was going to be 
important. In this sense the author hopes that his 
contribution may be thought to have been worthwhile. 
With the techniques available in the Virus Research 
Unit, some well known (density gradient zone electro-
phoresis, immune electron microscopy, affinity 
chromatography) and others developed in the Unit and 
modified for the present study (polymer precipitation with 
polyethylene glycol, ion exchange on formalin tanned 
gelatine granules and preparative immune-absorbent 
electrophoresis) it was hoped to break new ground. 
It was never the .intention to duplicate in Cape 
Town what others had done elsewhere. Large scale surveys 
of the local populations were not to be part of the 
programme, but it was thought to be important that anything 
found to be of immediate applicability to clinical 
diagnostic problems should be exploited to the maximum. 
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Three examples of this became evident during the course 
of the investigations: i. the demonstrations of 
hepatitis B antigen in sera (and in a commercial sample 
of immune globulin being used in the Hospital) when 
standard serological tests including radioimmune assay 
had failed to detect it, ii. throwing light on the problem 
of demonstrating hepatitis B antigen in faecal samples 
and iii. the development of a technique for the 
demonstration of anti-HBc, the antibody to the core of the 
Dane particle. Restrictions had to be placed on the 
temptation to start using one or more of the multitude of 
new techniques reported in the literature over the period 
that this work was in progress. 
While it would have been well beyond the scope of 
this thesis to review the enormous literature that has 
grown up about hepatitis B antigen and its antibodies, it 
was thought important to present a survey of the work of 
others, dealing with those aspects which have a bearing on 
the present study. With this in mind it was decided to 
consider the literature from four points of view. 
Historical perspectives. Changing concepts of the 
transmission of hepatitis B virus. Hepatitis B antigens 
and their intracellular sources. Hepatitis B antibodies, 
their specificities and their sequence of appearance. 




The aim of this investigation was to study some of 
the biophysical, biochemical and serological properties 
of the antigen which had come to be firmly associated with 
hepatitis B infection even before the responsible virus 
had been identified with certainty. In anticipation of 
the Dane particle having this key role, it was given a 
high priority for detailed examination. 
It was clear that the antibodies in patients 
recovering from acute hepatitis and in individuals who 
were chronic carriers of the hepatitis B antigen (HBAg) 
were directed against several antigenic components and 
these had to be distinguished from one another and 
separately assayed. A rather unique analytical situation 
therefore was presented by the serum of carriers in that 
the antigens and antibodies to be studied occurred 
together in the same starting material in mixtures of 
varying proportion, and sometimes as antigen-antibody 
complexes. 
The techniques used, provided components of HBAg in 
a state of purity and concentration satisfactory for 
detailed examination. Polymer precipitation with poly-
ethylene glycol 6 000 and ion exchange gave reproducible 
results in large scale fractionation procedures, and a 
specially designed apparatus (the "H-tube") provided 
purified samples of HBAg when only small amounts were 
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required. 
A particular consideration in the purification and 
concentration procedures was to separate the specific 
immunoglobulins from components of the antigen without 
damaging either. This limited the variety of acceptable 
techniques but gel filtration and ion exchange proved 
successful to the extent that the discrete components of 
antigen could be used in the electron microscope for the 
detection of a specific antibody. 
A careful study of the effects of various detergents 
and enzymes on the antigen had a number of important 
implications and applications . In the first place it was 
possible to disrupt the coats of the Dane particle to 
permit the release of the inner core components. This 
made it possible to show that the inner core was anti-
genically distinct and provided material for the detection 
of anti-HBc by electron microscopy. 
The biophysical effects of the detergent on the 
antigen components was reflected in the altered charge 
density on the surface shown by the increased migration of 
the treated particles under standard conditions in a 
sucrose gradient subjected to electrophoresis. This 
surface alteration in the presence of proteolytic enzymes, 
circumstances somewhat resembling the conditions in the 
intestinal tract where bile salts and bacterial enzymes 
abound, resulted in the complete dissolution of surface 
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antigen leaving the resistant Dane core particles which 
could only be detected by immune electron microscopy. This 
result made a material contribution to the controversy 
which had resulted in a spate of papers with a confusing 
list of claims · about the presence or absence of HBsAg in 
faecal samples. 
Another was the demonstration of a new antigen and 
its antibody which were designated HBIII and anti-HBIII 
respectively. This was described as the third antigen 
antibody system since HBs anti-HBs and HBc anti-HBc were 
already well known. The antigen proved to be a cryptic 
one, not present on the unaltered surface of the HBAg but 
demonstrable with reproducible ease by detergent treatment. 
The demonstration that this reagent exposed HB 111Ag, led 
to greater clarity in the matter. There is a current 
paper associating HB 111Ag with thee-antigen, and a recent 
letter to the Lancet (Neurath and Strick, 1977) suggests 
that e-antigen is a gamma globulin and that anti-e is an 
anti-gamma globulin. This is compatible with the concept 
of HB 111 and anti-HB 111 . 
A contribution to the somewhat conflicting reports 
of the presence or absence of normal serum components on 
the surface of HBAg was made by a study which showed 
convincingly that an antigen, detectable by anti-human 
gamma globulin (and a number of other. antisera directed to 
various loci of the gamma globulin molecule) using immune 
electron microscopy, was not found on the undamaged surface 
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of the antigen, but was regularly demonstrated after 
detergent treatment. Exposure of serum protein components 
(IgG, IgM and activated complement) was not confined to 
detergent effects but followed contact with caesium 
chloride, glycerol and other reagents used by investigators 
who had contributed some of the conflicting results. 
The suggestion is made that the demonstration of 
these substances as an integral part of the HBsAg in the 
serum of chronic carriers of hepatitis B virus indicates 
a continual production of antibody to the surface antigen. 
This concept has recently begun to replace the older idea 
of defective production of anti-HBs by chronic carriers. 
The investigation is thought to have been well 
worthwhile. Much of what is recorded in this thesis has 
been superceded by the tremendous pace at which new 
findings and techniques have continued to appear in the 
literature over the 4 years since the work was initiated. 
The participation in !Jl'e several controversies at the time 




1.1. INTRODUCTION HISTORICAL PERSPECTIVE 
The emergence of the identity of the hepatitis B 
virus from the mists and myths surrounding the causes of 
infective jaundice, began with the recognition of a 
distinct infective agent in human blood. 
Findlay and MacCallum (1937) associated the trans-
mission of acute hepatitis with the administration of 
yellow fever vaccine, which had been stabilised with human 
serum. At about the same time hepatitis following the use 
of convalescent measles serum was reported (McNalty, 1937 
and Propert, 1938). 
Yellow fever vaccine administration to United States 
military personnel in the early years of the World War II 
was associated with 28 585 cases of jaundice of whom 62 
died. An editorial in the Journal of the American Medical 
Association (1942) replied at length to allegations by the 
Chicago Tribune concerning the safety of the yellow fever 
vaccine and the validity of the safety trials of this 
product. 
MacCallum (1972) related an incident that occurred 
in 1942 when Sir Winston Churchill nearly received yellow 
fever vaccine. MacCallum was asked whether Churchill 
should receive the vaccine for protection whilst in transit 
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through the Middle East and was able to advise against 
inoculation on the grounds of insufficient time for 
immunity to develop. Subsequently a very irate Director 
of Medical Services of the R.A.F. who had received 
vaccine from the batch that would have been used for 
Churchill, developed jaundice. Once the concept of serum 
hepatitis was accepted it was possible to relate the 
reported incidence of syringe-transmitted jaundice to the 
imperfect sterilization of parenteral equipment and the 
administration of human blood products rather than to the 
therapeutic agents employed (Maccallum, 1943 and 1945). 
Retrospective confirmation was available in a publication 
by Lurman (1885),(whose lucid description of an o~tbreak 
of hepatitis amongst shipyard workers is reproduced in 
English by Zuckerman (1975),:~~rrectly ascribed the out-
break to a batch of human lymph used for smallpox 
vaccination. 
This impeccable logic was unmarred by ignorant 
postulates, a habit not infrequently encountered even in 
modern times, and the concluding sentence of his article 
notes that he was "not · in a position to supply an explan-
ation for this remarkable chain of cause and effect". 
This explanation was, at the end of World War II still 
only a well-informed postulate, but several workers, the 
first of whom was J.S.H. Gear in 1948, were able to 
demonstrate an immunological reaction between convales-
cent serum and either acute phase serum or liver extracts 
from hepatitis patients (Zuckerman, 1975) although it is 
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suggested that these were non-specific reactions (Maccallum, 
1972). 
It was not until 1963 that Blumberg~~-, while 
working on the antigenic specifications of low density 8-
lipoproteins by assessing the antibody response of multiply 
transfused patients, detected a precipitin line by a micro-
Ouchterlony technique between the serum of two of their 
panel of transfused patients and the serum of an Australian 
aboriginal. The antigen in this serum clearly differed 
from the serum 8-lipoproteins (Blumberg et al., 1965) and 
was named the Australia antigen. 
The distribution of this antigen amongst the normal 
population of various countries showed clearly that it 
occurred more commonly in tropical and crowded communities 
than in developed countries. However in America, where the 
incidence amongst the normal population was negligible, the 
antigen was found in a proportion of leukaemic patients and 
those with Down's syndrome and led Blumberg et~-, ll965) 
to propose the test as an early diagnostic tool for the 
detection of leukaemia and to postulate that the antigen 
may be related to a viral agent responsible for the 
induction of leukaemia. 
The pursuance of this side issue, no doubt associated 
with the institutionalisation of Down's syndrome patients 
and the need for repeated blood transfusion by leukaemics, 
was obviated by the observation and correct interpretation 
-12-
from all over the world that occurred between 1963 and 
1968, that Blumberg was honoured by the Nobel Prize 
Committee as co-recipient of the prize for Medicine in 
1976. 
Nonetheless it was Prince (1968) who firmly 
established the relationship between the Australia antigen 
and serum hepatitis and demonstrated that the antigen was 
not present in cases of infectious hepatitis. He investig-
ated a group of hepatitis patients and was able to detect 
the antigen in the blood of 10/12 patients incubating serum 
hepatitis but not in the blood at any stage of the disease 
in patients who were judged to have developed infectious 
hepatitis. This was confirmed by retrospective examination 
of some of the Willowbrook sera for the presence of 
Australia antigen (Giles~ al., 1969). The Willowbrook 
State School is an institution for mentally retarded 
children in which viral hepatitis had been endemic since 
1949~ with informed parental consent it was considered 
justifiable to gather data on the epidemiology and 
immunity of hepatitis by infectivity studies. These 
studies followed the work of Maccallum and Bauer (1944); 
Maccallum and Bradley (1944) on human volunteers in 
transmission experiments and of Havens et al., (1944); 
Stokes and Neef (1945) and Paul~ al., (1945) and 
established two ~cols of icterogenic serum designated 
MS-1 and MS-2 as representative of the two strains of 
hepatitis endemic at Willowbrook. The pools corresponded 
to the classical infectious hepatitis (MS-1 strain of 
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of two fortuitous episodes. One of the Down's syndrome 
patients converted to an Australia antigen positive state 
while under investigation and was found to have developed 
hepatitis coincidental with the conversion. Then a 
laboratory worker for the group developed jaundice and again 
the antigen appeared in her blood concommitant with the 
clinical illness (Blumberg, 1968). An investigation of sera 
from cases of viral hepatitis showed that the antigen was 
detectable in 10.4% of cases, (Blumberg~ al., 1967) and 
the association between the Australia antigen and hepatitis 
became more clear. However, the view of Blumberg's group 
in 1968 was that the antigen occurred in hepatitis, Down's 
syndrome, some forms of leukaemia and some apparently 
normal individuals resident in the tropics. They made the 
important observation that the antigen was persistent in 
some individuals and that it seemed that these people had 
an impairment of their immune mechanism which may be 
inherited. By rate zonal centrifugation of positive sera 
.th rough sucrose density gradients, fractions were obtained 
that were reactive for the Australia antigen. These 
fractions when examined by electron microscopy showed the 
presence of 190 - 210 Angstrom spherical particles as well 
as filaments of the same diameter and varying in length 
from 500 - 2 300 Angstrcim. These particles were found to 
be aggregated by prior incubation with human or rabbit 
antiserum to the Australia antigen (Bayer et~., 1968). 
It was for thi~ work, including both the discovery 
of the antigen and the vast amount of screening of sera 
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hepatitis A virus) and serum hepatitis (MS-2 strain of 
hepatitis B virus) and provided valuable information as to 
the infective dose, mode of infection and absence of cross 
immunity to the two strains as well as firmly characteris-
ing the clinical features of short (MS-1) and long 
incubation (MS-2) hepatitis (Ward et~-, 1958; Krugman et 
al., 1959; Krugman et al., 1962 and Krugman et al., 1967). 
Studies at Willowbrook also adequately demonstrated the 
occurrence of what is still a major problem, the 
persistence of hepatitis B antigen. In the first series 
reported (Giles et al., 1969) 50% of the recipients of the 
MS-2 serum, whether they received the serum by intra-
muscular injection or whether they were given it orally, 
remained positive for Australia antigen for at least 3 
years (the duration of the retrospective study.) 
So far, reported progress seemed to indicate that 
hepatitis B virus was about to give up all its secrets 
as the association of a simple test and demonstrable 
'virus' particle with clinical serum hepatitis enabled 
a large volume of mainly epidemiological data to be 
placed in correct perspective. Research efforts tended 
to centre on the virus itself and on the twin aspects of 
characterising the virus and propagating it in tissue 
culture. Initial attempts at assigning the small antigen 
to various classes of viruses were naive (Bayer et al., 
1968) and further confused by the reported presence of 
about 5% RNA in isolated antigen (Joswiak et al., 1971). 
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Perhaps the most significant basic finding was that 
the Australia antigen appeared largely to be composed of 
serum protein; B-Lipoproteins-(LDLJ,25 - 30%, IgG (the 
major protein component), B-1 a/c component of complement, 
albumin and transferrin were all identified by immunological 
means after three Tween 80 extractions of the purified 
antigen. (London et al., 1972). This observation received 
little attention at this time. 
It is now known that the material subjected to such 
intensive analysis did not contain the infectious virus in 
any significant amount and it was the surface antigen alone 
that was analysed. The first description of a larger part-
icle and the correct deduction that this represented the 
hepatitis B virus (I-IBV) was supplied by Dane et al., (1970). 
This large double shelled 47 nm particle has now officially 
been designated I-IBV (WHO: Weekly Epidem. Rec., No. 48, 
1976) but will hopefully retain its common name "the Dane 
particle." 
The evidence for allocating the role of virus to the 
Dane particle is in essence the result of the enormous 
amount of research both on the nature of the Dane particle 
and its morphology and occurrence as well as a study of 
the host immune response. This story really begins with 
the demonstration by Almeida et al., (1971) that the outer 
coat of the Dane particle, which had been shown to share a 
common antigen with the small particles (Dane et al. ,1970), 
could be split from an internal component by detergent 
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treatment. These inner cores were complexed by post-
hepatitis sera from patients with chronic renal failure 
(one had hepatitis 2 years previously) but not by the pre-
hepatitis sera or by control sera. The outer coats of the 
Dane particle and the small antigen were not aggregated by 
the post-hepatitis sera. However, sera from a haemophiliac 
with antibody to Australia antigen produced complexes with 
both the internal component and the surface material of the 
Dane particle and with the small components. This led 
Almeida ~ al., (1971) to suggest that the antibody response 
to the surface antigen is short lived and that the "normal" 
antibody response in hepatitis virus infection is to the 
core component. It is interesting to note, although this 
is not commented on, that chronic renal failure is assoc-
iated with a depression of the immune system and this may 
have been responsible for the "abnormal" response to surface 
antigen described in sera from their post-hepatitis cases. 
Of great significance was the realisation that the inner 
core of the Dane particle appeared to be identical in 
appearance with particles obtained from post mortem 
hepatitis livers prepared by Almeida et il·, (1970). 
1. 2.CHANGING CONCEPTS OF THE TRANSMISSION OF HEPATITIS B 
VIRUS 
Transmission of Hepatitis B 
The original definition of hepatitis type B infection 
(MacCallum, 1947) inferred that the agent was transmitted 
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parentally by blood or blood products and this hypothesis 
presumably held for a large proportion of type B infect-
ions, until the need for adequate sterilization of instru-
ments and routine screening of blood donors was realised. 
The most recent situation is reflected by reports of 
hepatitis Bin communities and by analysis of exposure 
factors (Heathcote and Sherlock, 1973) of index cases. In 
a series of 67 patients, 24% had likely parenteral exposure 
to hepatitis Band 40% had contact (non-parenteral) with 
HBAg carriers or acute hepatitis cases. Similar findings 
were reported for the West German district of Hannover by 
Mueller et al., (1975). The district included a city and 
its surrounds and involved a population of a little more 
than 1 million. Serum from all cases of suspected 
hepatitis were screened for HBAg and assessed for liver 
function abnormalities. HBsAg was found in 54% of confirm-
ed cases of hepatitis with an age incidence maximal at 24 
years and minimal before the age of 15 years. The HBsAg 
negative group on the other hand tended to be younger with 
the highest incidence of from 9 - 24 years, with a 
lowered incidence in the older age groups. 
Evaluation of the HBsAg positive cases provided a 
history of blood transfusion in the preceding 6 months in 
only 13.5 % with, at the other end of the spectrum, no 
history of surgery, dental treatment, injections, tatooing, 
drug addiction or contact (either occupational or social) 
with hepatitis cases in 21%. The remaining two thirds of 
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the HB Ag positive hepatitis patients had, within the six 
month period, been exposed to one or more of these hazards 
which may be considered unavoidable in developed commun-
ities. This epidemiology highlights some of the problems 
and gaps in the knowledge of the spread of infection and 
the immunity of a particular population group. Parenteral 
modes of spread are, in this study, possible in about 44%, 
and that presupposes that the listed exposures were 
indeed the source of the infection in every case. 
~uite obviously transmission occurs in the majority 
of cases by means other than by inoculation with infected 
blood by exposure to the medical profession and its sharp 
instruments. Infected blood may be the mode of trans-
mission in social contact, and a significant (10%) number 
had cont~ct with carriers or acute hepatitis cases. The 
mechanism of spread may depend on either the accidental 
inoculation of traces, or the ingestion of a more sub-
stantial amount of infected blood (Krugman et al., 1967; 
Westwood et al. , 19 7 3) . This has been shown possible by 
a number of reports and include early studies by Maccallum 
and Bauer ll944) in which MacCallum ascribes nasopharyn-
geal transmission of serum hepatitis to contamination of 
swabs with blood produced by the minute trauma of swabbing 
a throat (Maccallum, 1972). 
Norwegian track finders hepatitis was abolished by 
the use of protective clothing which prevented scratches 
from undergrowth and inoculation by twigs and thorns or 
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pools of water freshly contaminated with the blood of 
. 
preceding runners (Ulstrup et~-, 1974). Towels and 
water in communal bathing houses after the race (Zuckerman, 
1975) may have been a more likely method of inoculation 
with infected blood. 
Barker et al., (1970) showed that 1.0 ml of a ten 
thousand-fold dilution of infective plasma given parent-
ally will transmit hepatitis, that a million-fold dilution 
may produce sub-clinical infection, and this indicates the 
possibility of transmission by blood or blood containing 
natural secretions by inocula as small as those mechanic-
ally transferred by mosquitoes (Prince et al., 1972; 
Papaevangelou and Kourea-Kremastinou, 1974; Purcell, 1975) 
or bedbugs (Mazzur and Jones, 1976). Even cockroaches 
from a dialysis unit were found to retain detectable HBAg 
for 10 days after ingestion of infected material, although 
this finding may be of academic interest only. The ritual 
mutilations so common amongst primitive people (tribal 
markings, circumcision) are well described (Blumberg and 
Hesser, 1975) and must result in transmission. The rituals 
of civilization (barbering, teeth brushing, ear piercing) 
where instruments are shared, may with less frequency be 
implicated in the spread of type B hepatitis. 
Apart from cross inoculation by infected blood, 
there is a large volume of well documented information 
dealing with spread by contact alone (Lander et al., 1971; 
Ricci et al., 1973). The most readily acceptable category 
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relates to studies of families where a known carrier is 
involved (Szmuness et al., 1973; Irwin et al., 1974). 
Surveillance of renal dialysis patients who, because of 
the high risk associated with their presence in a dialysis 
unit, are relegated to home dialysis, has shown that house- · 
hold contact, but more particularly intimate contact, are 
clearly indicated as methods of spread. Sexual 
intercourse appea~to be significant and studies of 
prostitutes reveal a higher incidence of anti-HBs when 
compared with the general population, an incidence which 
increases proportionally with length of service in that 
profession (Adam~ al., 1974). Remarkably the carrier 
rate of HBsAg amongst prostitutes was not increased, 
suggesting an unusual form of successful vaccination. 
Both the antigen carrier rate, which was higher than the 
prostituteJ, and seroconversions were higher among nuns 
than in a control group from neither profession. A point 
that seems to have escaped the attention of the authors is 
that by using the nuns as an index of non-venereal trans-
mission, they had inadvertently chosen an Order which was 
engaged in active nursing in an institution in which there 
was a high incidence (40%) of endemic hepatitis. 
There are reports of HBAg detected in semen, saliva 
(Tanna et~., 1972; Heathcote et al., 1974) and Mazzur 
(1973) has hypothetically suggested transmission by 
menstrual blood. All these factors support the findings 
of a higher incidence of transmission between sexual 
partners than between other family contacts (Hersh et al., 
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1971; Mosley, 1972; Jeffries et al., 1973). 
Non-sexual transmission of infection is well 
recorded, particularly amongst inmates of children's 
institutions (Krugman et al., 1967) and a striking 
example of this type of epidemiology was provided by a 
report (Vernon et al., 1976) on a study of hepatitis out-
breaks among families who had adopted Vietnamese orphans. 
A high proportion (27%) of these orphans were found to be 
carriers (none were clinically ill with hepatitis) and the 
effect on the non-immune American community where the 
normal incidence of anti-HBs is 4.1%, was marked. Some 25% 
of the close contacts developed hepatitis B, this apart 
from an outbreak of hepatitis A associated with other 
numbers of these orphans. 
If it is accepted that exposure to blood by other 
than the parenteral route, may transmit hepatitis B, and 
as an illustration the pattern of infection in renal 
dialysis units may be cited, where the incidence of 
hepatitis B per employee time is up to 150 times that of 
the incidence amongst the general nursing staff (WHO; 
Wkly. Ep. Record, 1973) then inapparent parenteral 
inoculation, ingestion of blood and possibly inhalation of 
blood aerosols may be considered to be important methods 
of transmission. Nevertheless the endemic situation in 
low socio-economic status of countries and institutions 
where evidence of exposure to the virus may be present 1n 
25% (Mazzur and Jones, 1976) to 45% (Szmuness et al., 
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1973) of the community may not be based on infection by 
blood, or even blood contaminated natural secretions 
alone. 
A single report (Ogra, 1973) of a short appearance 
of HBAg in the nasopharynx of some patients may indicate 
a period of infectiousness. No mention of blood contam-
inating the nasopharyngeal samples was noted, but this 
may interestingly link with the Maccallum report lsee 
Maccallum, 1972) of transmission of hepatitis by naso-
pharyngeal swabs. Nasopharyngeal secretion of infectious 
virus would be expected to occur during the prodromal 
period of infection and for this reason must be difficult 
to demonstrate, so that even a single report may be 
significant. There is no doubt that HBAg can be detected 
in saliva during the period of antigenaemia, and most 
reports (Ward et al., 1972; Brodersen et al., 1974) were 
assessed by relating the presence of HBAg with that of 
occult blood, and although blood was detected in many 
specimens, HBAg was detected in a significant number of 
persons whose saliva contained no detectable haemoglobin. 
Probable transmission is recorded following a bite from a 
retarded child whose saliva was positive for HBsAg and 
negative for occult blood (CDC: MMWR, 1974). 
Whether this is a significant epidemiological find-
ing is doubted by Marcolongo ~ al., ll9 7 3) who were only 
able, by counter-electrophoresis, to detect HBAg in saliva 
in one out of twentyfive patients with acute type B 
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hepatitis. Interestingly, sweat was found to be positive 
in 40% of cases by the relatively insensitive technique of 
immunodiffusion LTelatar ~ al., 1~74) but it must be 
remembered that by the nature of the tests used for detect-
ing antigen in these secretions, a positive result is only 
dependent on the presence of surface antigen. This does 
not necessarily indicate the infectivity of positive samples, 
merely the presence of antigenic surface determinants. 
Indeed it would be expected that the HBV itself may only 
enter secretions as a result of leakage. Most reports 
stress the low level of HBAg in concentrated specimens as 
compared with the level detected in the serum of these 
patients. 
A single report of hepatitis B following accidental 
contamination of the eye of a nursing sister indicates that 
infective blood may transmit the disease through the con-
junctiva lKew, ·1973) but tears have been found to contain 
HBAg (Vittal et~., 1974). 
The infectivity of urine and faeces must be consid-
ered separately as the incidence of hepatitis B infection 
is increased in lower socio-economic populations (Cherubin 
et al., 19/2), a finding usually related to faecal-oral 
spread, and reports from Willowbrook LKrugman et al., 1967; 
Giles et al., 1969) amply indicate the high endemic rate --
prevalent in the institution due to natural spread. 
There is no direct confirmation of spread by this 
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route, early transmission studies are confused by the lack 
of specific tests for separating A and B type infections, 
and although the presence of serologically detectable 
antigen has been reported lSee Chapter 9) and morphological 
antigen isolated from faeces lTripatzis, 1972; Sonnabend 
et al., 1972) and detected in urine (Heathcote~ al.,1973) 
there is no recent study in the available literature of 
transmission experiments. Maccallum and Hradley (1944) 
reported transmission of hepatitis by ether-treated vanilla 
flavoured faecal homogenates in 3/26 cases. Unfortunately 
the source of the material is only listed as "from infect-
ive hepatitis cases", and the incubation periods are 
between 27 - 31 days, indicating transmission of hepatitis 
A. Indeed there is some evidence that among healthy adults 
there is little person-to-person spread, in particular 
troops receiving the hepatitis B contaminated yellow fever 
vaccine and an outbreak of hepatitis following plasm~-
phoresis experiments in 5 prison populations produced no · 
significant lateral spread (Mosely, 1972). 
Shellfish are known to concentrate toxins from sea-
water and outbreaks of hepatitis A have been associated 
with clams and oysters harvested from contaminated water 
lDougherty and Altman, 1962, and others). Blumberg and 
associates (Mahoney~ al., 1974) tested clams from bact-
erially polluted areas for hepatitis B antigen which was 
found in one area only, an area polluted with untreated 
effluent from a small hospital. It is tempting to assume 
that hepatitis B antigen is not present, in sewage even 
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when concentrated by bi-valves, except where contaminated 
with hospital efflux. 
After developing a sensitive assay for detecting 
HBAg in dilute fluids (Grabow and Prozesky, 1973) 
Grabow et al., (1975) were not able to detect HBAg in 2 
litre volumes of raw sewage nor in faeces (80-150 g) or 
urine (1 litre) from high titre HBAg positive patients. 
Blumberg and his associates (Mazzur et al., 1973) had 
shown a loss of immunological reactivity when HBAg was 
incubated with pseudomonas cultures and this was confirmed 
and associated with, in addition, a sensitivity to 
carboxy peptidase A demonstrated both for surface antigen 
and Dane core. Certainly the antigen is immunologically 
altered, whether it remains infectious (Mazzur et al., 
1973) would, in the light of present knowledge of the 
function of the Dane core, seem to be highly unlikely. 
It would appear that under these 'in vitro' conditions 
HBV and HBsAg are destroyed and that any transmission of 
the disease by the faecal-oral route, may be related to 
contamination of the excreta by blood or serum. As with 
saliva, transmission studies in chimpanzees would provide 
the only method of assessing infectivity. 
1.3. HEPATITIS B ANTIGENS AND THEIR INTRACELLULAR SOURCE 
In spite of this early exposition of the separate 
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specificity of the core of the Dane particle (HBc), immuno-
fluorescent studies of hepatocytes from livers of patients 
with Australia antigen positive hepatitis were clouded by 
the use of antisera which contained either anti-HBs or 
both anti-HBs and anti-HBc (Hadziyannis et al., 1972; 
Nielsen and El ling, 19 71). Brzoska et al. , ( 19 7 3) however 
were able to demonstrate the duality of the antigen by 
using serum from patients with acute viral hepatitis and 
chronic aggressive hepatitis to show nuclear fluorescence, 
and sera from hepatitis B antibody positive persons and 
hyperimmunised animals to show cytoplasmic fluorescence. 
This information is consistent with the knowledge that 
Brzoska and his associates (1973) had selected and prepared 
antisera with anti-HBs and anti-HBc specificity and that 
these antisera firmly located core antigen in the nuclei 
and surface antigen in the cytoplasm. The location of 
core antigen in the nuclei of infected hepatocytes had 
been indicated by Nowoslawski et al., (1970) and Nelson 
et al., (1970) who described virus-like particles in the 
nuclei of hepatocytes by electron microscopy in ultra~ 
thin sections, and this was confirmed by Blumberg's group 
(Huang, 1971) and serologically identified with ferritin 
C. 
and fluores~1n labelled guinea pig anti-HB serum (Huang 
et a l., 1972). 
Surface antigen in the cytoplasm of hepatocytes has 
been regularly demonstrated by immunofluorescence and the 
pattern of fluorescence, whether it be focal, diffuse or 
solitary correlated with clinical and histopathological 
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patterns of acute hepatic necrosis, chronic active 
hepatitis and chronic persistent hepatitis (Roos et al., 
1976). In addition, a correlation has been shown between 
eosinophilic "ground glass" hepatocytes in conventionally 
stained sections by light microscopy (increased smooth 
endoplasmic reticulum), orcein or aldehyde fuchsin 
positivity (Shikata et al., 1974; Deodhar et al., 1975) 
and anti-HBs fluorescence. Confirmation that this was the 
site of surface antigen production using electron micro-
scopic examination of ultra-thin sections was initially 
less convincing, especially in view of the large amount of 
surface antigen present in the peripheral blood. 
The early demonstration of occasional coated part-
icles, similar in size and morphology to the Dane particle, 
which were found in phagosomes and cell sap were not con-
vincing and may represent artifactual positioning during 
sectioning (Huang, 1971) but Stein et al., 1972(a) and (b) 
showed convincingly that the dilated cisternae of the endo-
plasmic reticulum of hepatocytes from 2 healthy carriers 
contained filaments which on cross-section appeared to have 
an electron dense centre. This "owl eye" appearance was 
similar to that of positively stained sectioned antigen 
obtained from serum. 
Further work by Huang et al. ,(1974) led to the 
distinction of the "owl eye" appearance of filaments in 
cross section from the appearance of Dane particles in 
cross section, both of which were reported in the endo-
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plasmic reticulum. Homogenates of the same liver preparat-
ions were negatively stained and intertwined bundles of 
filaments, tadpoles and Dane particles were isolated and 
found to be identical both morphologically and serologically 
with those occurring in serum. 
Gerber et al., (1972, 1973, 1974) reported similar 
findings and in addition found that the percentage of hepato-
cytes affected varied from 5% to virtually all the hepato-
cytes observed. Up to ten circular bodies were observed 
within the same cisterna and were usually accompanied by a 
flocculant material. Peroxidase labelled anti-HB reacted 
with the membrane of the smooth endoplasmic reticulum and 
with the intra-membranous particles. The authors suggest 
that the use of immunologically specific labelled antisera 
for core and coat would confirm their findings, but if their 
findings are judged in conjunction with those obtained by 
other techniques it must be clear that a site of surface 
antigen production has been satisfactorily demonstrated. 
The enormous mass of circulating surface antigen, 
when contrasted with the paucity of morphological antigen 
in hepatocyte cytoplasm in early electron micrographs, 
raised some doubt as to whether the liver alone produced 
all the antigen. The half life of surface antigen is un-
known, but this apparent inconsistency becomes more 
plausible when it is considered that there is both consider-
able proliferation of the endoplasmic reticulum in infected 
cells (Popper and Schaffner, 1976) and that the surface 
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area of endoplasmic reticular membrane has been calculat-
ed to be approximately 8 - 13 m2 for each 1.0 ml of 
normal liver tissue (Weibel et~., 1969). 
A recent publication confirms these findings (Trump 
et al . , 1976) and again demonstrates, by sections of 
infected hepatocytes , the proliferated endoplasmic 
reticulum, the profiles and cisternae of which contain 
circular and lamellar profiles 20 - 25 nm in diameter . 
The reference by authors to circles, circular or 
ellipsoid profiles or bodies points to the appearance of 
filamentous antigen in cross section, which on positive 
staining seems in some instances to have a central 
electron dense dot (Gerber, 1974). It is this appearance 
which in earlier works led to the discussion of the 
relationship of the coated particles to Dane particles . 
It seems obvious now that the cisternae contain 
packed filaments of HBAg positive material, arranged in 
twisted cords, and that some of these filaments are in 
tadpole form with terminal widening of the coat to enclose 
a core. Coated particles are also found and on negative 
staining of material produced from these cells by disrupt -
ion (Huang et al . , 1974) it would appear that these 
structures correspond to the Dane particles , tadpoles and 
filaments described in serum. Small spheres, so numerous 
in sera, were not obvious in homogenates of liver cells 
and may only be formed after release from hepatocytes . 
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The mechanism of production of this material is not known, 
and the original hypothesis of Dane et~., (1970) - that 
this represents excess coat production has not been 
invalidated by recent work. 
In considering the chronological events leading to 
an unravelling of the mysteries of the source of this 
unusual virus, progress towards the development of a tissue 
culture system and animal model for propagation and 
isolation of the virus must be mentioned. The benefits of 
such a system would be immense, both as a tool for further 
investigation of viral morphogenesis and for the evolution 
of vaccines. Many attempts have been made, both pre- and 
post-Australia antigen era, to isolate an infectious agent 
from cases of hepatitis in a variety of tissues from chick 
embryo to tobacc~ plant. (MacCallum and Bauer 1944; 
Banatvala, 1973). Growth of hepatitis B virus in culture 
has been reviewed (Nature, 1974; Zuckerman, 1975) but in 
spite of reports of individual successes in liver cell 
cultures and human embryo organ culture as judged by 
immunofluorescence or serological tests (Smith and Francis 
1972; Noyes, 1973; Shikata, 1973) and additionally by 
electron microscopy (Zuckerman et al., 1972; Zuckerman 
and Bird 1973; Panouse-Perrin et al., 1973), the results 
have not been generally reproducible. Recent comment that 
"the successful cultivation of hepatitis B virus in tissue 
or organ culture has not yet been achieved" (Krugman, 
197~, may be unfair to some individuals, does neyerthe-
less reflect the generally held view. 
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The report of an established cell line from a primary 
liver cell carcinoma (Alexander~ al., 1976) from a 
patient whose serum was positive for HBsAg and the 
identification by radio immunoassay and reversed cell 
haemagglutination techniques of hepatitis B antigen in the 
uninoculated cell culture supernatant fluid (McNab et al., 
1976) may provide a means for investigating the host/ 
virus relationship. 
Non-human primates provide an alternate to human 
volunteers for transmission and immunity studies of the 
hepatitis B virus and fortunately, after initial confusion 
occasioned by the later demonstration of 6 - 12% pre-
existing immunity of captive chimpanzees,(WHO 1973), this 
animal shows mild symptoms of infection following inoculat-
ion with the virus. 
Maynard et~., (1972) were responsible for the 
initial demonstration of infection with hepatitis assoc-
iated antigen by sere-conversion and this antigen was 
demonstrated for them in the serum of an inoculated 
chimpanzee by electron microscopy. Barker et~., (1973) 
showed the presence of HB antigen specific fluorescence 
in the hepatocytes of an infected chimpanzee and subsequent-
ly continued transmission experiments establishing the 
parameters of the mild illness produced. At this stage 
the significance of the duality of HBAg was more fully 
realised and in 1974 the Barker group reported progress as 
a result of chimpanzee experiments in the study of the 
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second type of antibody (anti-HBc) and its association 
wj_th viral replication. Small amounts of core antigen 
had previously been available only from liver biopsy 
material or from preparations from serum and this had 
hampered the development of serological tests for the 
presence of anti-HBc. A cyclophosphamide suppressed 
chimpanzee died from pneumonia after being experimentally 
infected with hepatitis Band the liver of this animal 
contained numerous intra-nuclear cores, which when 
extracted, provided sufficient core antigen for radio-
immunoassay and complement fixation. This allowed the 
retrospective study of sera collected weekly from human 
infectivity studies conducted in 1951 - 1954. The 
patterns of serological response were estab~ished for 
acute infection, abortive primary infection, development 
of the carrier state and anamnestic response (Hoofnagle 
et~., 1973; Hoofnagle et al., 1974; Hoofnagle et~., 
1975). 
A further link in the chain of evidence that the 
HBV is present in Australia antigen was provided by the 
detection of endogenous DNA polymerase in crude pellets 
of antigen (Hirschman et al., 1971) and this activity was 
shown to be associated with cores obtained from detergent 
treated Dane rich sera by Kaplan et al., (1973) who 
demonstrated a sub-population of Dane cores in the sucrose 
density gradient fraction containing the polymerase 
activity. Inhibition of enzyme activity by actinomycin D 
and daunomycin indicated that the polymerase was DNA 
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dependent, although Hirschman and colleagues had suggested 
that the reaction was RNase labile, and confirmation of 
this came from the detection of actinomycin D, 
poly(dA-dT) -poly(dA-dT) inhibited DNA polymerase activity 
in the serum of experimentally infected chimpanzees 
(Bradley et al., 1974). These workers were able to 
correlate the appearance of polymerase activity in the 
serum with infection, and demonstrated its appearance in 
several peaks prior to evidence of liver dysfunction and 
the appearance of circulating HBsAg. 
Some of the co-workers in the original detection of 
DNA polymerase, (Robinson et al., 1974) were able to react 
DNA polymerase with purified cores and obtain core struct-
ures with a radioactive DNA product. After extraction 
with sodium dodecyl sulphate examination of the banded 
radioactive material from a caesium chloride gradient by 
flotation technique produced the first electron micro-
graphs of the small double stranded circular DNA molecule. 
Circular DNA was also released from cores without reaction 
with synthetic label. After the necessary steps of first 
treating the core preparation with DNAse to remove un-
protected DNA, disruption of the core provided circular 
DNA molecules. The open configuration of the DNA molecule, 
and thermal denaturation and enzyme studies additionally 
indicated both the double strand and a G+C content of 49%. 
The length of the molecule was determined by measuring 225 
circular strands to give a mean of 0.78µ m (780nm) to 
correspond to a molecular weight of about 1.6 x 106 
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daltons. This is smaller than the double stranded DNA 
of any known virus and the genetic information carried 
must be very limited, ft is suggested that this may 
only be sufficient to code for the proteins associated 
with coat antigenicity, the nucleocapsid antigen and 
the DNA polymerase. The additional peptides identified 
in coat material would seem to be beyond the capacity 
of the genome. Hung~ al., (1975) have essentially 
confirmed these findings by reporting that the tritiated 
circular DNA from Dane particles hybridizes with free 
DNA in HBs carrier plasma but not with DNA prepared from 
normal liver extracts. 
All the evidence for considering the core of 
the Dane particle to be the nucleocapsid of the HBV is 
present and indeed the title has been officially 
conferred{WHO: 1976). It is obvious however that this 
infectious agent, the subject of an immense volume of 
research compressed into less than a decade, will 
continue to absorb the interest of investigators for a 
long while to come. At the present time, because of 
some of the anomalies described, there is talk of 
"helper viruses", hypothetical "infectious particles 
with larger DNA molecules","excess coat protein 
production" and much reference to this "unique virus", 
the signs of indecision and confusion that tend to 




HEPATITIS B ANTIBODIES, THEIR SPECIFICITIES AND 
THEIR SEQUENCE OF APPEARANCE 
The pattern of serological response to infection by 
the HBV has been well documented by (Hoofnagle et al., 
1973, 1974, 1975) and by Krugman, Ward and Giles from 
Westbrook (reviewed by Krugman, 1975). Antibody to the 
surface antigen, anti-HBs, usually becomesdetectable in 
serum after the disappearance of circulating HBsAg and 
coincident with the abatement of jaundice or biochemical 
dysfunctions. The development of more sensitive assays 
showed that although the titre may be low, most patients 
with acute hepatitis develop an antibody response to 
HBsAg even although this may be months after the acute 
disease (Robinson and Lutwick, 1976). It has been 
postulated recently (Melnick et~., 1976) that anti-HBs 
may be produced at low levels continuously throughout 
the stages of hepatitis, but the formation of immune 
complexes inhibits the manifestation of antibody until 
the level of HBsAg falls. Evidence to support this 
concept is presented elsewhere in this thesis. 
The complement fixation test developed by Hoofnagle 
et al., (1973) for measuring anti-HBc levels had a profound 
influence on the understanding of the temporal relationship 
between persistent infection in the carrier and the anti-
body response. It was clearly shown that anti-HBc was 
associated with continuing viral replication and that this 
antibody developed early in infection. The detection of 
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anti-HBc seems to coincide with liver damage, but is 
preceded by the appearance of HBsAg in the circulation. 
All chronic carriers lpersistence of HBsAg in the serum 
for more than 3 months) are shown to have high levels of 
anti-HBc, although not all have easily detectable evidence 
of liver damage. Mild infections characterized by 
anicteric hepatitis and a shortened period of HBs anti-
genaemia produce a transient level of anti-HBc as evidence 
of HBV replication. Certainly no anti-HBc response has 
been noted in patients who have received inactivated vlrus 
lKrugman et al., 1974). ln their description of the sero-
logical responses to HBV infections determined retrospect-
ively by titration of anti-HBs and anti-HBc, Hoofnagle and 
his co-workers (1975) included the pattern of response 
resulting from re-exposure to the virus three months after 
an attack of acute hepatitis. This demonstrated an 
anamnestic response to coat material alone, but does not 
necessarily show that this is the protective antibody, 
certainly no evidence of core replication, as judged by a 
rise in anti-HBc titre, was found in these cases. 
Recent third generation tests for anti-HBc (Robinson 
and Greenman, 1974; Purcell et al., 1974) have largely con-
firmed the findings of Hoofnagle and Krugman, but an immune 
adherence test for anti-HBc developed by Mayumi and 
associates along the lines of an original third generation 
test for surface antigen (Mayumi et al., 1971) has shown 
in contrast to the American reports, that anti-HBc is more 
prevalent than anti-HBs amongst healthy Japanese blood 
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donors. This may be explained by the increased sensitivity 
of the test (approximately 10-fold) or by differences in 
the carrier rate of the two countries (Tsuda et al., 1975). 
As a routine test it may detect the HBsAg negative/anti-
HBs negative convalescent donors mentioned previously who 
may still have low levels of circulating immune complexes 
and be responsible for some of the 59% (Prince et al., 
1975) or 50% (Alter et al., 1972) of HBAg negative blood 
units that transmit hepatitis B infection. 
It is becoming increasingly clear that the immuno-
logical competence of the host determines the pattern of 
the response to infection by the hepatitis B virus. The 
host with normal immunological mechanisms will clear the 
virus completely after an acute clinical illness, but the 
host with a less efficient immune mechanism may present 
with a less acute hepatitis, with slight or even no 
jaundice and is more likely to become a chronic carrier 
of the hepatitis B antigen (Dudley et al., 1972a and b). 
The mechanism of this immunological reactivity has not 
been demonstrated, but immunofluorescent studies have 
shown that granular deposits of membrane-fixed IgG are 
present on isolated hepatocytes prepared from the livers 
of patients with HBAg positive acute hepatitis (Hopf et 
al., 1976). Effector lymphocytes (K cells) may be 
responsible for this antibody dependent cytotoxicity 
(Sherlock, 1976). Humoral antibody may be considered an 
important and readily detectable marker of the immune 
response and the evaluation of the specificities of the 
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immunoglobulins to the various components of the HBAg 
could be expected to convey important information pertin-
ent to the pathogenesis of hepatitis and the carrier 
state. 
The normal immune system seems to respond vigor-
ously to the virus and the result may be severe, even 
fatal, hepato-cellular destruction, whereas a reduced 
immune response or state of irnrnunosuppression results 1n 
mild clinical disease (Sherlock, 1976). The humeral 
response to HB virus infection may be used to measure the 
immune reaction to at least the presently known anti-
genic determinants of the hepatitis B antigen. The surface 
antigen is antigenically complex and there are multiple 
specificities within this antigenic system (Levene and 
Blumberg, 1969; le Bouvier, 1971). A group-specific 
determinant~ is present in all HBsAg positive sera and two 
pairs of mutually exclusive sub-determinants,~ or land 
~ or ~~seem to represent virus sub-types. The antigenic 
types appear to breed true, that is the index and second-
ary cases may be shown to possess identical sub-types, and 
this indirect evidence indicates that the sub-types are 
phenotypic expressions of viral genomes rather than antigen 
variations determined by the host (Reviewed by Robinson 
and Lutwick, 1976). 
Distinct from this system and of importance in the 
pathogenesis of the disease, is thee-antigen and its 
antibodies. This family was detected by Magnius and 
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Espmark (1972), who noted the appearance of precipitin 
lines in a double diffusion agarose gel when HB antigen 
positive serum from renal dialysis patients was placed 
adjacent to HB antigen positive serum from a multiply 
transfused haemophiliac. Further characterization of this 
system (Magnius, 1975), once it had been shown that thee-
system was associated with type B infection (Eleftheriou et 
al., 1975), showed that it differed from HBAg in essential 
physico-chemical properties. In particular, the molecular 
weight of 300 000 daltons and a sedimentation coefficient 
(S) of 11.3 indicated that Magnius was investigating a 
soluble antigen of intermediate globulin dimension and 
not an antigen on the surface of HBAg particles. Both el 
Sheikh et al., (1975) and Nielsen et al., (1974) found a 
high correlation between Dane particles in sera and 
e-antigen and Nordenfeldt et al., (1975) showed an 
association between this antigen and DNA polymerase 
activity. During the investigation of 70 HBAg carriers, 
Feinman et al., (1975) found that e-antigen was 
associated with abnormal liver biopsies characterised by 
portal infiltrates and that e-antigen occurred in those 
carriers who had normal liver biopsies or less severe 
forms of hepatitis. In a small series of chimpanzee and 
human cases of hepatitis, e-antigen was associated with 
nuclear core antigen; those cases with definite anti-e did 
not reveal core antigen in hepatocyte nuclei in spite of 
the demonstration of HBs antigen in the cytoplasm in five 
out of six biopsies (Murphy et al., 1976). The authors 
admit that the biopsies may not have been truly represent-
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ative. Thee-antigen has been detected early in acute 
hepatitis, even during the incubation of the disease 
(Magnius et al., 1975; Nielsen et al., 1974) but was not - --
detected 1n 99 cases of acute hepatitis with no sequelae, 
although 14% of these cases developed anti-e. 
Persistence of e-antigen indicates a more serious prog-
nosis and up to 44% of cases of chronic active disease have 
detectable e-antigen in the serum (Eleftheriou et al., 
(1975). Similar findings were reported by Nielsen et al., 
(1974) and Fay et al., (1975). Vogten et al., (1976) 
associated e-antigen with failure to clear HBsAg and to 
respond to treatment with steroids. 
The increased infectivity of e-positive HBsAg is 
also indicated in a study compiled by Grady (1976) in 
which transmission of infection following accidental 
inoculation of medical personnel was twice as high when e-
antigen was detected 1n the contaminating blood. This 
incidence should not be considered alone, as other 
aetiological factors may be present in the series, 
especially as the study included dialysis staff. It was 
also shown that the incidence of e-antigen amongst HBAg 
positive dialysis patients was considerably higher (76%) 
than in other areas (28%). 
In an important study, stimulated by the ,obser-
vation that HBAg positive mothers could be separated into 
two groups by assessing vertical transmission of thee-
antigen, Okada et al., (1976) screened 23 mothers for the 
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presence of e-antigen and e-antibody. All the babies born 
toe-antigen positive mothers (10/23) were HBsAg positive, 
as were elder siblings; thee-antigen negative mothers 
(7/23) did not transmit the HB antigen to their babies. 
In addition, all maternal sera withe-antigen contained 
Dane µarticles which were not detected in those sera which 
had antibody toe. 
The antibodies of thee family may be considered 
evidence of an immunological response toe-antigen, a 
soluble, non-particulate antigen occurring in sera which 
show evidence of hepatitis B infection in that they are 
infective, contain Dane particles and are associated with 
active liver disease. In acute hepatitis, e-antibody 
occurred as early as the fifth week after the onset of 
jaundice in a small series reported by Eleftheriou et al., 
(1975), and before the disappearance of HBAg. The occur-
rence and persistence of e-antibody in a wider sense remains 
largely unprobed and awaits the development of a more 
sensitive screening technique. 
Recently a link between the soluble antigen of 
Magnius and the morphological forms of hepatitis B antigen 
has been described. Neurath ~al., (1976), using 
affinity chromatography, purified antibody toe-antigen. 
Immune electron microscopy showed that thee-reactive 
site was present on the Dane particles and on the 
filamentous forms of the surface antigen. 
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Neurath and Strick, (1977) in a letter to the 
Lancet, have recently amended this view and indicate 
that e may be isolated by insolubilised antibodies to 
human IgG (but not anti-IgM or antibodies to non-immuno-
globulin serum proteins). They suggest that e-positive 
molecules, eluted from the immunosorbent, are dimers (or 
higher polymers) of a 7S immunoglobulin and may be anti-
antibody. Experimental details are not given, nor is the 
amendment to the earlier publication clear in respect of 
the isolation of e-determinant Dane particles and 
filaments. The physicochemical properties of the 
e-positive molecules would now seem to be similar to 
those characterised by Magnius (1975). 
It is apparent from the literature that thee 
family of antigens consists of at least two sets of 
reactants (Magnius, 1975; McAuliffe et al., 1976) and 
cross reactions are possible. The significance of this 
family may be of great use clinically (Sherlock, 1976) 
as the presence of e-antigen may be used prognostically 






In the light of the frequent application of poly-
ethylene glycol (PEG) to a wide variety of fractionation 
procedures in this laboratory, it was decided to investig-
ate the possibility of using this polymer for the isolation 
and concentration of HB antigen from human serum. In the 
absence of other sources of this antigen, except in very 
rare instances, it was most essential to have a standard 
procedure for preparing HBAg in large quantities and in a 
suitably purified state from plasma, for future 
experiments. 
Selective precipitation by PEG of proteins (Polson 
et al., 1964) of viruses (Polson and Deeks, 1963) and of 
bacteriophages (Yamamoto et al., 1970) is now commonly 
used as one of the steps in fractionation procedures of 
complex mixtures. 
The use of the polymer is empirical and conditions 
must be experimentally determined for each system. Juckes 
(1971) has defined some of the parameters concerned, 
based on the concept that the process is one of colloid 
phase sep aration. Polson (1972) has developed the theory 
that the protein is displaced from solution by super-
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concentration in the inter-PEG spaces. 
The solubility of the protein either alone or in 
a mixture of proteins such as plasma, would seem to 
depend on a concentration of the protein(s), the ionic 
strength and pH of the mixture, as well as the size of 
the protein molecule. To establish the parameters and 
to standardise the fractionation procedure, variations in 
the preparation pattern may be minimized by diluting the .. 
plasma with Sorensen's buffer thus ensuring a relatively 
constant pH and protein concentration. At pH 8.6 the 
charge difference between albumin and globulin increases 
and this has been shown by Polson and Parker (1973) not 
only to enhance the separation of these two fractions 
but to render the albumin free of HB antigen. 
The parameters for the fractionation of HBAg 
from serum by polymer precipitation were unknown at the 
time of the initial experiments in the present study, 
but since it was important to have a ready method for 
procuring concentrated HBAg from serum a standard 
procedure using PEG was developed. High levels of purity 
at this stage were not critical but in the processes of 
concentration and separation, retention of morphological 
integrity of the Dane particles was essential. 
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METHODS 
The procedures evolved in this study are described 
below. Pulverised PEG was used in Method la; PEG in 
solution was used in Method lb; Method 2 is an example of 
differential precipitation obtained by altering the pH 
of the solution while the PEG concentration remains 
constant. 
METHOD la. Fractionqtion with pulverised polymer (PEG) 
Polyethylene glycol m.w. 6 000 was pulverised in a 
mortar until smooth, or in a Waring blender for the rapid 
preparation of bulk amounts. 
The plasma to be fractionated was diluted 1:3 with 
-Sorensen's buffer pH 8.2 and the pH checked and adjusted 
PEG 5% w/v was slowly added to the diluted plasma 
which was kept briskly stirred by a magnetic stirrer, 
.until the PEG was completely dissolved. The mixture was 
allowed to stand at room temperature to allow phase 
separation to reach completion, and the precipitate removed 
from the mixture by low speed centrifugation at 1 000 x g 
20 min. The supernatant fluid was decanted into a 
measuring cylinder and the new volume determined. The 
concentration of PEG in the supernatant could then be 
calculated from the formula 
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v1c1 = v2c2 
where v1 is the volume in ml of the original diluted serum 
and c1 the concentration of PEG in gm per 100 ml. v 2 is 
the volume of the SNF and c2 is the new concentration of 
PEG in gm per 100 ml. Pulverised PEG is added in the same 
manner to bring the concentration in the supernatant up to 
20% and the resultant precipitate 1s packed by low speed 
centrifugation. The supernatant fluid was carefully 
discarded. The surface of the sedimented pellet and the 
walls of the centrifuge tube were gently rinsed with dis~ 
tilled water to reduce contamination of the pellet by PEG. 
A volume of modified Sorensen's buffer pH 8,6 equal to the 
original plasma was delivered into the centrifuge tube and 
the pellet dissolved in situ with the aid of a small 
magnetic stirrer. This was a solution of what was 
designated for convenience the "20% PEG precipitate." 
In order to ascertain the advantages of re-precipit-
ation of this product, the dissolved 20% PEG precipitate 
was subjected to further fractionations by sequential 
additions of more PEG. The cycle was commenced by the 
addition of 2% w/v of PEG to the solution, the removal of 
the precipitate, the determination of the volume of the 
supernatant, and the recalculation of the amount of PEG 
in the supernatant. The concentration of the polymer was 
then increased with the addition of 2% PEG with each step 
in the process until a 10% concentration was reached. 
The last increment was of 5% PEG to give a final con-
centration of 15 % PEG. These precipitates were designated 
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"2% to 15% PEG re-precipitates" and each was separately 
dissolved in phosphate buffer pH 7.2 in a volume equal 
to 1:5 of the original plasma volume. 
METHOD lb. Fractionation with a 30% solution of PEG 
Another procedure that was investigated made use of 
a 30% solution of PEG. The volume of this solution 
required to give a particular final concentration of PEG 
was calculated from the formula 
= 
where c1 is the concentration of PEG in gm per 100 ml; 
v 1 , the volume of PEG solution in ml; v0 , the volume in ml 
of the mixture to be fractionated, and C, the required 
final concentration of PEG in gm per 100 ml. 
Example: To determine the volume of 30% PEG solution that 
must be added to 25 ml of diluted serum to give a PEG con-
centration of 10% (gm per 100 ml). 
30V1 = 10(25 + V 1) 
30V1 
= 250 + lOV1 
20V1 
= 250 
v1 = 12.5 ml of the 30% PEG solution 
METHOD 2. Fractionation with pulverised PEG and pH shift 
The 20% PEG precipitate from Method la was diluted 
with phosphate buffer pH 3.5 in a ratio of 1:3 and the pH 
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While stirring, pulverised PEG was slowly added to 
the mixture to provide a concentration of 7% w/v PEG. The 
fine precipitate that formed was removed by low speed cen-
trifugation and the pH of the mixture raised to 4.2 by 
adding crystalline Na 3Po 4 . The resulting heavy precipitate 
was removed and dissolved in phosphate buffer at pH 7.2. 
RESULTS 
METHOD 1. 
The plasma fractions, precipitates and supernatants, 
produced by the different concentrations of the polymer 
were evaluated by electrophoresis in agar gel or on cell-
ulose acetate and also examined in the electron microscope 
for the presence or absence of hepatitis B antigen. 
The initial precipitation with PEG removed visible 
impurities from the plasma, including residual cell debris. 
Electrophoresis of this fraction showed a single peak of 
precipitated protein in the position of fibrinogen. Only 
a trace of antigen .was present in this fraction. 
Electrophoresis of the "20% PEG precipitate" showed 
that a separation of the remaining proteins had been 
achieved but with some overlapping on either side of a line 
centred about the region of the alpha globulins. The "20% 
SN F" ( P 1 ate 2 . 1. a . , F i g . 2 . 1. a . ) contained none of the g amm a 
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-50-
and beta globulins. The "20% PEG precipitate" (Fig ,2 ,1 .b.) 
had most of the gamma globulins with the alpha and beta 
globulins and a small amount of the albumin. 
Re-precipitation of the "20% PEG precipitate" with 
10% and 15% PEG produced a displacement of the gamma 
globulins and some of the other globulins at 10% PEG con-
centration (the ''.1.0% PEG re-precipitate") (Fig. 2.1.c., 
Plate 2.1.a.) followed by most of the remaining globulins 
present in the fraction at "15% PEG re-precipitate" 
(Fig. 2.1.d., Plate 2.1.a.) 
Observations on the effects of sequential 2% 
increments of PEG added to the solution of the "20% PEG 
precipitate'' are presented in Plate 2.1.a. The serum 
fractions found in the resulting precipitates varied marked-
ly. This procedure made it possible to decide on the most 
appropriate treatment for the isolation of the HB com-
ponents. 
The flow-chart, Table 1, lists the steps of the two 
Methods 1 and 2. Each precipitate and each supernatant 
was examined by electron microscopy for the presence of HB 
antigen. Many of them gave unrewarding yields of one or 
other of the components of HB antigen, but the results of 
the most successful isolations are positioned alongside the 
relevant fraction. Complexed HBAg was removed by re-
precipitation with 2% PEG (Plate 2.1.b.). It will be seen 
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by two distinct populations. The "10% PEG re-precipitate" 
contained apparently all the Dane particles, most of the 
filamentous forms and a proportion of the small spheres 
(Plate 2.2.a.). The "15% PEG precipitate" contained an 
almost homogeneous population of small spheres with 
occasional short filamentous forms not. longer than twice 
the diameter of the spheres (Plate 2.2.b.). 
The number of Dane particles and filamentous forms 
increased with each 2% increment of PEG, and the maximum 
yields were with the 8% and 10% concentrations of the 
polymer. 
METHOD 2. 
The precipitate produced by re-precipitation of the 
"20% PEG precipitate" at pH 3.5 with 7% PEG was found to 
contain no detectable serum proteins by electrophoresis 
on cellulose acetate or by immuno-electrophoresis in 
agarose gel using anti-human serum prepared in rabbits. 
Shifting the pH to 4.2 without altering the PEG con-
centration resulted in the formation of heavy precipitate 
which, on electrophoresistproved to consist almost entirely 
of globulins. 
On electron microscopy the HB antigen was present 
only in the initial precipitate formed at pH 3.5. None of 
the antigen appeared in the precipitate at pH 4.2. In the 
former, the HB antigen consisted of small spheres only and 
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2.2.a. Large component HBAg displaced by re-precipitation with 10% 
PEG from the dilute solution of the "20% PEG precipitate". 
Magnification x 80 000 
( ~ m ;-..r-s:~~;:-.....:ip~~~~m~~~~,,.,~~~ 
2.2.b. Small spherical antigen displaced from the SNF of the 10% 
PEG re-precipitation of the "20% PEG precipitate" 1.Jy increasing the 
concentration of PEG to 15% w/v. Magnification x 80 000 
PLATE 2.2. 
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was not associated with detectable serum proteins. 
Although the surface structure of the antigen appeared to 
. I . 
have lost some detail, one dimensional Laurell electro-
phoresis in a gel con{aining anti-HBs confirmed the high 
concentration of HBs antigen in the .pH 3.5 fraction and 
absence of HBs antigen in the fraction produced at pH 
4. 2. 
The influence of temperature on these fraction-
ation procedures was noted in the initial experiments . No 
appreciable difference was observed when the procedures 
~are carried out in parallel on the same sera, one at 4°C 
and the other at room temperature of 22°C. All fraction-
ations were thereafter performed at ambient room temp-
erature. 
DISCUSSION 
The removal of fibrinogen from plasma with 5% PEG 
w/v had the additional advantage of cl arifying the serum 
by precipitating cell fragments and denatured lipoproteins 
present in some of the plasmas which had been stored for 
long periods of time. The loss of very small amounts of 
HB antigen in the precipitate was presumed to be as a result 
of co-precipitation by the mass of precipitated fibrinogen. 
The most optimistic anticipations at the commence-
ment of these investigations were that PEG would achieve 
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one or more of several goals. It was thought that if 
due attention were paid to the parameters ~nown to 
influence the outcome ~f the .fractionation p noc~dures, 
such as the protein concentrat.ion of the mixture:, the pH, 
the ionic strength and the polymer concentration, it 
might be possible 
,I 
i. to separate and concentrate the components of HB 
antigen in the serum sample 
ii. to separate and concentrate the gamma globulins in 
the serum 
iii. to separate i from ii. 
These expectations were not fully realized but the 
attainments and success were such as to be of inestimable 
value in the subsequent investigations. 
On the assumption that a relatively high concent-
ration of serum proteins and individual variations in lipo-
protein content might adversely influence the displacement 
of the I-IB antigen by PEG, the serum was regularly diluted 
with buffer. This step was shown to be important and this 
was confirmed b_y many fractionations of sera from 
different patients in the routine preparation of I-IB 
antigen for investigation. 
The steps in the fractionation procedure listed in 
Table 1 represent a selection of the very many variations 
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of polymer concentration and conditions of pH and ionic 
strength that were tried in attempts to produce the 
optimum re~ufts. Even using very small 1ncrements in PEG 
coficentration failed to select a set of conditi6hs where 
separation of HB antigen from serum proteins' was complete. 
' j i, ,' 
I , 
It is obvious however .that the "10% PEG re-precipitate" 
' ; 
gave the most worthwhile results, and this was used as 
the standard method of preparation of antigen thereafter, 
whep Dane particles were required and the "15% ·PEG re-
precipi tate" when small spheres alone were nee'de'd. 
Although this proved to be a useful division 
between the morphological forms of the antigen, it was 
clearly not one that depended solely on particle size. 
Antigen which remained in solution after 10 % PEG precipitat-
ion, consisted almost entirely of small spheres of very 
uniform shape, while the precipitated antigen contained 
all the Dane particles, the filamentous forms (longer 
than 2 sphere diameters) and approximately 1/3 of the 
small spheres. 
An attempt was made to correlate the mean diameter 
,. ,, .. .. 
of the insoluble small spheres with that of the soluble 
small spheres at this concentration of PEG. Electron 
micrographs of these two fractions were assessed using a 
micro-comparator. A hundred spheres of each of these 
samples were measured using arbitrary units and the means 
of the two diameters compared. No correlation was 
detected in size and it was presumed that other factors 
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such as surface charge density, govern the separation of 
the small spheres at this intermediate point . . A similar 
' .. 
finding was reported by Neurath ~ al., (1973a) at 
\ \ I 
neutral pH and under differ~nt ionic conditions. 
The small spheres precipitated by 15% PEG had the 
advantage that serum prote'ins were markedly reduced and 
that it was relatively free of antibody globulins. On 
\ ! ~ 
j \ •, 
the other hand the use of the large component fraction 
.• :• l,. l. i: \. 
precipitated by 10% PEG was complicated by the co-
precipitation of immunoglobulins which frequently included 
antibodies to the HB core or other cryptic antigens. 
The presence of HB antigen and the appropriate HB 
antibody results in the formation of antigen-antibody 
complexes under certain conditions. Small numbers of 
complexes in serum samples containing large amounts of HB 
antigen may be very difficult to detect in the electron 
microscope, but by re-precipitation of the samples with 2% 
PEG, complexed antigen of the larger classes were 
displaced without rendering Dane particles and the larger 
filaments insoluble. Such small increments of PEG were 
selectively used to detect immune complexes when present 
in small numbers. 
Method 1 therefore provided a preparative tech-
nique for the concentration of semi-purified antigen from 
plasma. The one disadvantage of this method was the co-
precipitation of immunoglobulins with the large components 
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of the HB antigen. For many subsequent investigations it 
was essential that the immunoglobulins be separated from 
the antigen, particularly when it became obvious that most 
of the donors, who had become carriers of HB antigen, had 
' : Ii\ 
in their serum an antibody directed to an inner component 
l , ( 1 ' 
of the Dane particle. Nevertheless this method quickly 
and easily provided concentrated antigen in two population 
siz~s, if necessary from large volumes of plasma, but with 
the large component fraction always associated with immuno-
globulin. To separate these two components by polymer 
precipitation an additional step was introduced. The iso-
electric point (pI) of the macroglobulins is centred at 
pH 6.0; that of the heterogeneous antigen extends from 
pH 4.5 - 5.4 in unfractionated samples, to pH 3.9 4.9 
for purified antigen (Chairez et al., 1975). This 
difference in solubility at these pH points allowed polymer 
precipitation linked with pH shift to be used. When the 
concentration of the polymer was kept constant at a level 
which would induce displacement only in conditions of 
minimal solubility, that is within one pH unit of the pI 
of the protein, the pH was shifted sequentially to allow 
the differential exclusion and separation of these 
components (Johnson and Newman, 1972 and 1974). 
Method 2, based on this hypothesis, utilized the 
first step of the precipitation of HB antigen and its 
globulins by 20% PEG. The precipitate was dissolved in 
buffer at pH 3.5 and 7% PEG was added. As judged by 
quantitative Laurell electrophoresis with anti-HBs in the 
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gel, all the HB antigen components were precipitated. On 
shifting the pH to 4.2 with the PEG concentration remain-
ing at 7% w/v, a heavy precipitate was produced which was 
shown to consist of globuljn~. This procedure thus 
separated HB antigen from . the immunoglobulins present in 
the donor's serum. On electron microscopy the preparat-
ion was found to consist of small spheres only, in spite 
of the presence of an abundance of the large components in 
the original serum. As the purpose of the fractionation 
was to provide a source of immunoglobulin-free Dane 
particles for serological study, the loss of these 
particles rendered the method unsuitable for immune 
electron microscopy. 
The retention of HBs reactivity of the damaged 
antigen is in keeping with the findings of Dreesman et al., 
(1972) who treated Dane containing HBAg at pH 2.4 for 1 
hour and recorded the loss of large components from the 
purified HBAg. This preparation was used to determine the 
molecular weights and isoelectric points of hepatitis B. 
Antigenic activity was retained and antiserum raised in 
guinea pigs did not show any activity against normal 
human serum components. 
Nath et al., (1976) have recently described a --
procedure for obtaining HBAg from plasma by precipitation 
with PEG 4 000. This PEG was added to undiluted plasma to 
a concentration of 8% w/v and the precipitate was removed 
and discarded before the concentration in the SNF was 
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raised to 16%. The precipitate produced by this increment 
of PEG contains the HBsAg, which was then digested with 
pepsin at pH 2.3 and treated with Tween 80. The antigen 
so prepared was not examined in the electron microscope, 
but was found to have a molecular weight of greater than 
100 000 daltons and to be suitably pure for serological 
use. 
Exposure to low pH, or detergent (Tween 80 and 
Mucasol) has an easily discerned effect on the morph-
ology of the antigen, the Dane particle in particular, but 
this does not destroy the antigenic integrity of the HBsAg 
(Gerin et~., 1969; Chairez et al., 1975; Stannard and 
Moodie, 1976). The pH shift described in Method 2, 
although damaging to Dane particles and filaments, was 
shown to be suited to the preparation of HBsAg for 
serological procedures. 
The recent observations by Nath et al., (1976) 
though differing in detail from the procedures developed 
in the course of the present study, gives clear 
confirmation of the necessity for the rather complex 
preparative procedures to obtain a suitable preparation 
of hepatitis B antigen. 
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Chapter 3 
THE PREPARATION OF DANE PARTICLES AND THE CORE ANTIGEN 
INTRODUCTION 
The importance of the Dane particle and the growing 
need to investigate some of the antigenic properties of 
its coat and its core, required preparations for electron 
microscopy which were both rich in Dane particles and 
free from iso-antibodies. The inner core antigen (HBcAg) 
was known to have a determinant separate from the surface 
antigen (HBsAg) (Almeida et al., 1971) and it was suspect-
ed that antibody to this component was commonly present in 
Dane particle containing sera. 
The antigen-antibody complexes reported in the sera 
of chronic carriers (Stannard et al., 1973) could largely 
be removed by the 2% PEG re-precipitation step (Chapter 2) 
before concentration of the large component antigen of 
Dane particles and filaments. This provided a preparation 
of HB antigen free of complexes that could be used for 
the detection of antibodies by immune electron microscopy. 
The presence of the antibody would then be manifest by 
the formation of new complexes with the homologous antige~ 
Simple separation of the antigen in diluted serum 
by high speed centrifugation followed by two washes in 
phosphate buffer was time consuming and produced a low 
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yield of antibody-free Dane particles. Hoofnagle et al., 
(1973) using HBcAg obtained from chimpanzee livers, con-
firmed that all Dane particle-containing human sera 
possessed anti-HBc activity and also demonstrated the 
presence of this antibody by complement fixation in the 
sera of all chronic carriers tested. 
The presence of anti-HBc 1n the serum of a carrier 
could be used as a test for the effective removal of anti~ 
body globulins from Dane particle preparations. Treatment 
of the preparation with a suitable detergent (e.g. 2% 
Mucasol) to release the cores of the Dane particles, 
provided a precise and sensitive reagent for the detection 
by immune electron microscopy of anti-HBc by the resultant 
formation of core complexes. 
This permitted the critical evaluation of two 
simple additional methods for producing globulin-free 
large component antigen suspensions. The first of these 
procedures (Section 3.2.) is based on the size differential 
between HBsAg and the globulins, and the second (Section 
3.3.) exploited the difference in net surface charge. 
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METHODS 
3.1. Differential Ultracentrifugation 
An aliquot of 0.5 ml of plasma or serum was 
diluted with 0.06 M phosphate buffer pH 7.2 in a cell-
ulose nitrate tube (1.25 x 5.0 cm) of the Beckman SW 50 
rotor. The diluted serum was clarified by centrifugation 
at 12 000 x g for 10 min and the supernatant fluid re-
centrifuged at 50 000 x g for 60 min. The sedimented 
pellet was thoroughly dispersed in 0.5 ml of the buffer 
before the tube was refilled with phosphate buffer, 
inverted once to ensure mixing, and re-centrifuged at 
50 000 x g for 60 min. The wash was repeated before the 
tube was inverted, and allowed to drain. The pellet was 
suspended either in one drop of distilled water before 
staining with 2% phosphotungstic acid for electron 
microscopy, or alternatively in 0.25 ml PBS for sero-
logical reactions before preparation for immune electron 
microscopy. 
3.2. Gel Filtration 
Commercially prepared agarose beads (Pharmacia Fine 
Chemicals AB, Uppsala, Sweden) were diluted with phosphate 
buffer pH 7.2 to an easily workable consistency, de-
aerated and packed, with stirring, to a bed height of 35 cm 
in a 2.5 cm chromatography column. The flow rate was con-
trolled by a sigmoid pump and the eluate was monitored by 
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u-v absorption at 280 nm. The void volume was deter-
mined using the haemocyanin molecule (mol wt 7.9 x 106 
daltons) of the mollusc Burnupena cincta, the common 
whelk (Polson et al., 1970). Samples of 2 ml each were 
applied under buffer on to the gel surface with the pump 
switched off. To facilitate this the density of the 
sample was increased by the addition of sucrose crystals 
(approx. 5% w/v). After stabilization of the applied 
sample, as shown by the development of a sharp buffer/ 
sample interface, the pump was re-started at a flow rate 
of 12.5 ml/h. Fractions were collected in 1 ml amounts 
to each of which 1.0 ml of 4% Mucasol was added and the 
mixture stored overnight at 4°C. Next day the 2% Mucasol 
mixture was incubated at 37°C for 1 h before being 
prepared for electron microscopy. 
3.3. Ion Exchange on Formalin Tanned Gelatin Granules 
Hepatitis B antigen containing serum was dialysed 
against three changes of 20 times its original volume of 
0.005 M phosphate buffer pH 5.5 at 4°C, each change 
occurring at approximately 12 h intervals. After 
dialysis the pH was checked to be 5.5 and the 'euglobulin' 
precipitate removed by low speed centrifugation. 
Bed material consisting of packed 6% formalin tan-
ned gelatin granules (Polson and Katz, 1968), approximate-
ly four times the volume of the original serum, was 
equilibrated with buffer and drained without suction in a 
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Buchner funnel. The dialysed serum was added to the 
gelatine granules and the mixture gently stirred with a 
wooden spatula for 10 min. Mild negative pressure was 
applied to the Buchner funnel and the fluid which drained 
from the gel was collected. The gel was washed with one 
volume of 0.005 M phosphate buffer pH 5.5 and the washing 
added to the previous fluid yield. The pH was adjusted 
to 8.6 with crystalline Na 3Po4 before small increments 
of pulverised PEG were added, with stirring, to a 
concentration of 15% w/v. 
The solution was allowed to stand at room temper-
ature for 40 min before the fine excluded material was 
removed by centrifugation at 20 000 x g for 20 min. This 
material was dissolved in a small volume of 0.06 M 
phosphate buffer pH 7.2 and all insoluble material 
removed by centrifugation at 12 000 x g for 10 min. 
RESULTS 
3.4. Differential Centrifugation 
Antigen prepared by differential ultra-centrifug-
ation was relatively free of serum proteins. Its suitabil-
ity as a core antigen for electron microscopy (i.e. the 
absence of core antibody, anti-HBc) was shown simply by 
incubating the 2% Mucasol-treated-antigen at 37°C before 
screening the preparation for the presence of core 
complexes. Such antigen preparations now had no anti-HBc 
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and were therefore free of immune complexes. 
The control for this procedure was provided by 
overnight treatment of whole serum known to contain anti-
HBc, by 2% Mucasol followed by incubation at 37°C for 1 h. 
The formation of Dane core complexes is easily established 
by electron microscopy as shown in Plate 3.1.a. 
Gel Filtration 
The u-v absorption pattern of the molecularly 
sieved material depended on the type of the starting 
material fractionated. An elution diagram of HBAg-
positive serum chromatographed on 6% Sepharose beads is 
shown in Fig. 3.1.a., but since an identical tracing was 
obtained with HBAg-negative whole serum, no evidence of 
HBAg was apparent by spectrophotometry. Examination of 
the fraction from the initial high peak A which was at 
the void volume and consisted of totally excluded 
material, showed that it contained the large components 
of HBAg by electron microscopy. HB antigen was found in . 
diminishing amounts in peaks A, Band half way into C, 
but the large component antigen was found only in the 
rise and central third of peak A, whereafter the 
proportion of large components of antigen dropped and in 
the latter part of this peak only small spheres were 
present. Small spheres could also be detected through 
peak Band into peak Cat which point they were scattered 
and widely separated. 
Bed : Sepharose 
Column : 35 x 2 ,5 cm 
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-68-
Gel electrophoresis showed that peak C consisted 
mainly of albumin and that globulins extended from peak 
B through to peak C. 
The tracing in Fig. 3.1.b. represents the elution 
diagram of the 10% PEG re-precipitate fraction on 
Sepharose 6B. Peaks A and Bare again represented as 
in Fig. 3.1.a. but peak C is much reduced. Electro-
phoresis showed that most of the material in this peak 
was gamma globulins with very little albumin. Quantit-
ative assay of this fraction on Tri-Partigen plates 
after concentration to the original volumes gave values 
of IgM 32 mg/100 ml and IgG 640 mg/100 ml. Large 
component antigen was present in peak A and electron 
microscopic examination after detergent treatment showed 
that there was no antibody to the released cores. 
Using Sepharose 4B instead of 6B the ratios of 
peak A to peak B changed. Large antigen components were 
found in peak A. Small spheres were present in peak A 
and extended into B. Globulins were spread broadly 
from small amounts in peak B to constitute the major 
portion of peak C. The appearance of the Dane particles, 
filaments and small spheres, slightly altered by 
detergent treatment, is illustrated in Plate 3.1.b. 
There are no complexes of Dane cores and no anti-HBc. 
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3.1.a. Detergent treated whole serum. Dane core complexes. 
Magnification x 120 000 
3.1.b. Sepharose 4B fraction from peak A. Detergent treated and 




Ion Exchange on Formalin Tanned Gelatin Granules 
The light precipitate formed in the cold when serum 
was dialysed against low molarity buffer, was dissolved 
in 0.06 M phosphate buffer pH 8.2 at room temperature and 
evaluated by electrophoresis in agarose gel before 
discarding. Gamma globulins together with small amounts 
of alpha and beta globulins and trace amounts of albumin 
(Plate 3.2.a.) were detected. On electron microscopy no 
antigen was detected in this sample. 
After cation exchange of the dialysed serum by 6% 
formalin tanned gelatin granules, the supernatant fluid 
contained the HB antigen, but no gamma globulins detect-
able by gel electrophoresis. LC-Partigen plates con-
firmed the absence of IgG and IgM but showed the presence 
of a trace of IgA. The buffer used to wash the tanned 
gelatin contained only a small amount of albumin. 
Trial precipitation of the supirnatant, with the 
added buffer wash, by 15% PEG at pH 5.5 showed that under 
these conditions some of the HB antigen was not 
precipitated. Precipitation of the same supernatant 
fluid mixture with the pH increased to 8.6 resulted in 
the displacement of all the HB antigen by 15% PEG with 
only small amounts of protein (mainly albumin and S-
lipoproteins) detectable by gel electrophoresis. (Plate 
3.2.a.7.). Examination of this antigen under the electron 









3.2.a. 1% Agarose gel electrophoresis (pH 8.6) of fractions from ion 
exchan~e (see Section 3.3.) on formalin tanned 6% gelatin granules 
pH 5.5 
1. HBAg +ve serum diluted 1:5 in buffer pH 8.6 
2. Concentrated solution of precipitate formed on dialysis of the 
serum to molarity 0.005 and pH 5.5. 
3. Original serum after dialysis to molarity 0.005, pH 5.5. 
4. Post cation exchanged serum pH 5.5. 
;t. SNF of post cation exchanged serum 15% PEG pH 8.6 HBAg -ve. 
~~. Solution of 15% PEG precipitate (10 x concentrated) HBAg +ve. 
3.2.b. HBAg from 7b (above). 
PLATE 3.2. 
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the majority of the Dane particles were intact. After 
Mucasol treatment no antibody molecules were to be seen 
on the exposed cores. 
DISCUSSION 
Preparing small amounts of HBAg for electron 
microscopy by ultracentrifugation was the most simple and 
reliable procedure, but was time-consuming where 
repetitive screening was required. 
Gel filtration is an obvious choice for separating 
large component antigen especially when concentrated 
preparations are available and when very large scale 
fractionations are not needed. The size differentiation 
between the small antigen with a molecular weight of 
2.5 x 106 (Howard, 1975) or 3.7 - 4.6 x 106 daltons 
(Chairez et al., 1975) and the globulins (IgM 890 000 
daltons; Merler, 1970) should allow separation by 
molecular sieving. In practice this was achieved and if 
polymeric or aggregated globulin contaminated the HBAg 
containing preparation, specific anti-HBc was not 
detected. Both Burrell et al., (1973) and Howard and 
Zuckerman, (1973) used Sephadex G 200 for partial 
purification of antigen from serum proteins, but agarose 
beads with higher flow rates and quick packing properties 
were found to be adequate for producing globulin-free 
large component antigen. Both Sepharose 4B (exclusion 
limit 20 x 106) which retarded large and small HBAg 
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(Fig.3.l. c.) and Sepharose 6B (exclusion limit 4 x 10
6
) 
which voided large antigen (Fig.3.1.b.) had the added 
advantage of partially separating small spherical antigen 
from the Dane particle containing components. 
The starting material used for this separation 
procedure should be the concentrated large component 
antigen and the source of such material was available in 
the re-precipitation fraction of the PEG fractionated 
material. This 10% re-precipitate could be stored at 4•c 
and (with the addition of 5% sucrose) layered directly 
on to the column. The fractions collected immediately 
after the void volume could be used without further con-
centration for immune electron microscopy and 0.5 ml of 
this material was found to be a "grid dose". The term 
"grid dose" was used to imply the volume of a suspension 
of antigen which when sedimented and washed, yielded the 
correct amount of antigen for the evaluation of one 
procedure by electron microscopy. Too much antigen 
present in the sample gave rise to overdense particles 
on the grids and the consequent masking of th~ antigen/ 
antibody complexes. Too little, although allowing fine 
resolution of detail, caused practical problems in stain-
ing and coating of the grids and sometimes made the 
addition of bovine serum albumin obligatory in order to 
produce sufficient surface tension to coat the grid. 
This emergency measure clouded resolution so that 
molecules of antibody were lost in the background of the 
added protein. 
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The gel filtration method was developed for the 
production of anti-HBc-free Dane particles for screening 
sera for the presence of core antibody and for studies on 
the Dane core and its antibodies. The advantage of this 
method was the production of batches of semi-purified 
antigen which could be stored and utilised when necessary. 
The degree of purity was adequate for immune electron 
microscopy. 
The separation of HBAg from globulin by ion exchange 
was limited by the effect of low pH on the Dane particles. 
Examination by electron microscopy of antigen prepared 
from a series of experiments at varying pH values, showed 
that exposure of the antigen to pH below 5.2 resulted in 
a disruption of the Dane coat. In addition changes were 
noted in the surface structure of the small antigen which 
under extreme conditions (pH 3.7) became unrecognisable. 
These changes were similar to those caused by glycine/HCl 
buffer pH 2.45 described by Hirschman et al., (1973). 
Initial experiments using both PEG precipitated 
fractions and whole serum indicated that a pH value 
intermediate between that of the iso-electric points of 
HBsAg, 3.8 - 4.1 (Howard and Zuckerman, 1973) or 3.9 - 5.3 
(reviewed by Melnick et al., 1976) and the globulins 
(pl 6.1 - 6.8) could make use of the opposite charges of 
these two components to achieve separation. It was found 
that the upper limit of pH required for the adsorption of 
all the globulins to the anionic gel was pH 5.2 but at 
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this pH the large component antigen showed signs of damage. 
Fortunately, pre-dialysis of the serum atf;'s.s was found 
to enhance the ion exchange mechanism by removing the 
buffering effect of serum and allowing the slightly 
higher and unharmful pH to be used. The low molarity of 
this dialysate must also contribute to the maximal dis-
placement of the counter-ions by the positively charged 
globulins, and the results of this single batch ion 
exchange showed that the globulins were extremely 
successfully removed by the procedure. These globulins 
could be recovered by elution with 0.14 M NaCl solution 
and the gelatin regenerated by displacement of the 
gradient ions and equilibration to starting conditions. 
The globulin eluted from the gel could constitute a 
source of human anti-HBc. 
The dilute ion exchanged supernatant fluid con-
tains the acidic serum proteins and HBAg. Separation of 
these two components is not necessary prior to detergent 
treatment of the Dane particles to release antibody-free 
cores. However, the action of the detergent is more 
predictable and rapid if the HBAg is precipitated from 
the serum proteins. Separation and concentration is 
relatively easily achieved with PEG precipitation. It was 
found that the pH should be raised to 8.6 to increase 
separation of HBAg from albumin as at the lower pH of 
5.5, complete displacement of HBAg was not obtained. 
Hepatitis B antigen without contaminating globulins, 
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and suitable for detergent treatment to release cores 
was produced by three steps; dialysis, ion exchange and 
PEG precipitation. Large amounts of donor serum were 
processed and treated with detergent. Isolation of the 
released cores by affinity chromatography of this 
detergent treated material on cyanogen bromide-activated-
agarose beads (CN-Sepharose) with anti-HBc globulin as 
the ligand was attempted but failed to release detect-
able cores after elution with lM NaCl or 4 M sodium 
thiocyanate. This may have been due to the destructive 
effect of the chaotropic ion on uncoated cores, or to 
non-specific absorption of released cores to the gel 
aggravated by inadequate numbers of cores. 
Two reports in the literature indicate successful 
isolation of small quantities of Dane core particles from 
serum. Lipman et~., (1973)used gradient centrifugation 
with both a detergent (Nonidet-P40) layer above a 
Ficoll/sucrose D2o gradient and a CsCl gradient. 
Although debated in the report, clear evidence of anti-
HBc is present on the cores in micrographs of prepar-
ations which banded at 1.28 (CsCl) and these antibody-
coated cores were non-reactive to anti-HBc. Some antibody-
free cores were obtained at a density of 1.29 - 1.30 in 
caesium chloride and these reacted with concentrated anti-
HBc in gel diffusion. More recently Fauvel et~-, (1975) 
isolated HBAg by centrifugation of serum at 100 000 x g 
for 25 hover a 45% sucrose cushion followed by twice 
banding in CsCl. Dane rich fractions were identified and 
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further purified by sucrose density gradient, detergent 
(Tween 80) treated and the released cores separated by 
rate zonal centrifugation in a sucrose gradient. This 
material produced antibody-free cores which were used 
for immune electron microscopy. 
The successful preparation of a large amount of 
core antigen from 5 1 of plasma has been reported by 
Tsuda et al., (1975). These workers used a zonal rotor 
(Beckman CF 32) with a continuous flow rate of 1.2 1/h 
and a peripheral cushion of 60% sucrose to perform the 
initial isolation of Dane rich fractions. The fractions 
(300 ml) were further separated by large scale gradients 
of CsCl and sucrose in special rotors, treated with 
pronase, detergent (NP 40) and mercaptoethanol before 
complete separation of HBcAg from HBsAg by sucrose 
gradient was achieved. This HBcAg was used in an immune 
adherence haemagglutination assay to screen 215 sera for 
anti-HBc. 
Despite the procedures developed by Lipman~ al. 1 
1973; Fauvel et al., 1975 and those in the present study 
the need for large amounts of pure core antigen for assay 
of anti-HBc may be obviated by the development of a 
micro-SPRIA assay by Purcell et al., (1974). Human anti-
HBc, labelled with 125 r is used to detect the amount of 
added HBcAg bound by the test serum. The small amount of 
HBcAg needed is simply prepared by detergent treatment of 
washed Dane particle containing antigen. Because of the 
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specificity of the radio labelled anti-HBc,there is no 
need to remove HBsAg from the preparation. 
The Dane particles and core antigen produced by 
the three methods of ultracentrifugation, gel filtration 
and ion exchange were found to be suitable for immune 
electron microscopic assay of anti-HBc and for studies 
of the antigenic complexity of the Dane particle. 
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Chapter 4 
PREPARATIVE IMMUNO-ABSORBENT ELECTROPHORESIS 
INTRODUCTION 
Mead (1958) described a method for separating one 
from a number of soluble antigens by driving the mixture 
by electrophoresis through a gel column containing a 
gradient of antibodies to all the components except the 
one it was required to harvest. 
This method has been applied to the separation of 
HBAg from human serum (Moodie and Polson, 1973). Anti-
serum raised in rabbits to normal human serum which 
contained no HBAg detectable by counter electrophoresis or 
by electron microscopy was used. This rabbit anti-
human serum was fractionated with PEG and the globulin 
fraction further purified by preparative electro-
phoresis (Step 1) to remove components that migrate 
towards the anode. The buffer· chosen was of low 
molarity and of pH 8.8 thereby balancing the negative 
charge of the globulins against the endosmotic flow. 
Agarose was used in the column in preference to agar as 
the elimination of the charged agaropectins in agar 
reduced the endosmotic flow (Polson and Russell, 1967). 
The shape of the apparatus was modified from the 
U-shaped tube used by Mead (1958) to two communicating 
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vertical limbs (the "H-tube") which facilitated the pour-
ing of agarose and the layering of material to be subject-
ed to electrophoresis. Since the electrophoretic 
inhomogeneity of the immunoglobulins ensured the formation 
of a gradient in the gel, the prior establishment of an 
antibody gradient (Mead, 1958), was found to be unnecessary. 
The technique is described in some detail, not only 
as an alternative method for preparing HBsAg from whole 
plasma but, since the separation is serologically depend-
ent, as an immunoabsorbent filter on a preparative scale. 
All human serum components are immobilised in the gel by 
the rabbit antiserum so any components migrating through 
the gradient of antibodies in the gel may be considered to 
be abnormal. 
The success and efficiency of this preparative 
technique required the assumption that normal serum com-
ponents were not present on the surface of the HBsAg. Two 
opposing views had been expressed on this point. 
Antigenic determinants related to normal serum 
proteins (albumin, pre-albumin, apolipoproteins and 
immunoglobulins) which were reported by Neurath et~., 
(1974) to be present on the HBsAg, were detected by 
affinity chromatography. Antisera to serum proteins were 
immobilised by cyanogen bromide linkage to Sepharose 4B. 
In their experiments HBsAg was absorbed to, and could be 
eluted from, the gel when the ligand was specific anti-
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body to these normal serum proteins. These findings were 
challenged by Goudeau et al., (1974) who showed that 
absorption of HBsAg could be prevented by pretreating 
the immunoabsorbent with 1% bovine serum albumin and by 
using TRIS buffered saline of relatively high (O.S) 
molarity. Neurath's reply, indicated (that he felt) that 
contaminating serum proteins were present in the 
"partially purified HBsAg" used by Goudeau et ~-, and that 
these inhibited binding of HBsAg to the anti-normal human 
serum immobilised on the gel (Neurath, 1975). In con-
sidering the two conflicting reports, it is of interest 
and indeed of utmost importance to note that the antigen 
used by Neurath et al., (1974) in their original 
experiments was purified by a method that included 
glycerol gradient separation (Neurath et al., 1973 a and 
b). (Elaboration of the significance of this technical 
point will appear later in this thesis). 
The use of the "H-tube" apparatus and the immuno-
absorbent electrophoresis technique made it possible to 
contribute positively to the controversy because 
(i) non-specific absorption was avoided by 
driving the antigen by electrophoresis through semi-solid 
agarose; 
(ii) the HBsAg was unaltered and undamaged by 
prior fractionation procedures and 
(iii) a gradient of antibodies to normal human 
serum components was present, so that saturation of anti-
body binding sites was unlikely. This should have ensured 
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that HbsAg was exposed to graded concentrations of rabbit 
anti-normal serum proteins. 
METHODS 
The "H-tube" apparatus used in this procedure is 
illustrated in Fig. 4.1. Two 20 cm x 2 cm vertical limbs 
were joined by a 7.0 cm horizontal tube of similar 
diameter. The left-hand limb was fitted with a tapered 
ground glass joint and bridged at its lower end by a No. 5 
sintered glass filter disc (D). The lower openings of 
both limbs were flared to facilitate the attachment of 
cellophane dialysis tubing of appropriate diameter. The 
tubing was secured above with cotton thread and closed 
below by knotting the distal end. A small amount of 
buffer was introduced into the left-hand limb and forced 
by positive pressure through the sintered glass filter 
into the sac (S) to ensure that all the air in the sac 
was similarly sealed with cellophane and filled with 
buffer. 
The "H-tube" was clamped vertically to retort 
stands and the lower ends immersed in separate vessels 
containing the buffer. Each vessel in turn communicated 
with an electrode vessel (EV) in which the silver/silver 
f.JR/J 
X chloride electrode (E) ~ placed and covered with a 






A ANTIBODY GEL 
B SPACER GEL 
C ANTIGEN GEL 
D SINTERED DISC 
E ELECTRODE 
EV ELECTRODE VESSEL 
s CELLOPHANE SAC 
FIG .4.1. IMMUNO-ABSORBENT ELECTROPHORESIS 
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Step 1 
Agarose 2% was melted in 0.02 M Tris/glycine/ 
barbitone buffer, pH 8.8, and allowed to cool in a bath 
of water at 43°C. Anti-human rabbit globulin 4.0 ml was 
warmed to 43oC in the water bath and immediately mixed 
with an equal volume of the 2% agarose in buffer by 
inversion. This mixture of 1% solution of agarose, and 1/2 
dilution of antibody in 0.01 M buffer was poured into the 
left-hand limb of the "H-tube" and allowed to gel (A). A 
spacer gel (B) of 8.0 ml of 1% agarose was poured on to 
the antibody-containing-gel and the column filled with 
buffer. 
A direct current of 4 volts per cm was applied with 
the anode at the left-hand limb. Electrophoresis was 
maintained for 24 h. At the end of this period the current 
was switched off and the dialysis bag below the gel 
removed and the contents collected. 
Fresh tubing was applied to the same limb, secured 
with cotton thread, and the tubing was filled with buffer 
and knotted under water to avoid air bubbles. 
Step 2 
The sample of HBsAg containing serum to be subject-
ed to electrophoresis was warmed to 43°C and immediately 
mixed with an equal volume of molten 2% agarose at the 
same temperature. After removing the buffer from the 
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column, the mixture was poured on to the surface (C) of 
the spacer gel of the left-hand limb. When this had 
gelled the apparatus was filled with buffer and electro-
phoresis was recommenced at the same voltage as in Step 1 
for a period of 48 h. At the end of this time, the 
contents of the dialysis sac of the anodal limb were 
carefully collected, and the walls of the dialysis 
membrane washed with a small quantity of buffer to ensure 
the recovery of any material that may have become attached 
to the wall of the cellophane sac. 
RESULTS 
Step 1 
Analysis of the fluid collected from the dialysis 
sac at the end of Step 1 i.e. prior to the addition of 
the antigen containing material, invariably revealed 
only the faster migrating gamma globulin, small amounts 
of alpha and beta globulins and a trace of albumin. 
Step 2 
After completion of the preparative electro-
phoresis, fluid from the sac contained HB antigen on 
electron microscopic examination (Plate 4.1.a.) and this 
antigen corresponded in morphology with that of the 
starting material. IgG, IgM or IgA human immunoglobulins 
were not detected in this fluid by radial immunodiffusion 
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4.1.a. HBAg prepared by immuno-absorbent electrophoresis. 




4.1.b. Central portion of an immuno-electrophoresis plate. Outer 
wells contained fluid from dialysis sac of "H-tube" on completion of 
Step a. Central well: normal human serum. Troughs: horse anti-
normal human serum. 
PLATE 4.1. 
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in Tri-Partigen plates. However electrophoresis of the 
material from the dialysis sac did demonstrate a component 
extending from the point of application to the position of 
the 8-1 lipoprotein, which on further analysis by immuno-
electrophoresis using horse anti-human serum, proved to 
be a single component of wide electrophoretic heterogen-
eity (Plate 4.1.b.) and of uncertain nature but possibly 
derived from the HB antigen particles or perhaps soluble 
elements of the HB surface antigen. 
DISCUSSION 
The results obtained from a series of experiments, 
as exemplified by the one recorded above, indicated that 
the simplest method of preventing contamination of the 
HBs antigen by fast migrating components of the antiserum, 
was not to rely on purification of antiserum before 
mixing with the gel, but to use a preliminary electro-
phoresis to clear the antibody containing gel of anode 
migrating components before applying the mixture of 
antigens. This ensured that variation in buffer, pH and 
agarose purity were rendered harmless since any 
components of the rabbit antihuman serum entering the sac 
were removed before the electrophoresis of the HB antigen 
containing material commenced. 
The presence of albumin and faster migrating gamma 
globulins in the sac at the end of the preliminary 
electrophoresis confirms the necessity of the step. During 
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this phase, the slowly migrating globulins were moved 
upwards by endosmosis into the spacer gel from the under-
lying antibody containing gel, and due to the in-
homogeneity of the antibody, a gradient of antibody was 
formed. The second step of the technique was performed 
with HBAg positive serum incorporated into a gel layered 
over the antibody gradient and driven into the gradient 
by electrophoresis. Bullet-shaped precipitin bands which 
developed in the spacer gel during electrophoresis were 
visible evidence of the reactions between normal human 
serum components and the immunoglobulins in the rabbit 
antiserum. Optimal proportions were estimated by pre-
liminary one- dimensional Laurell electrophoresis with 
A. 
trial dilutions of the anti-human serum in the gel. From 
the height of the resultant precipitin lines, it was 
possible to estimate the correct dilution of antiserum to 
be used in the "H-tube" column. This was not felt to be 
a critical determination as the length of the gel in the 
limb of the column is sufficient to accomodate a wide 
variety of reactions at differing optimal proportions. 
Partially purified and concentrated HBAg preparat-
ions would no doubt have yielded more HBAg without 
increasing the antigenic load on the antiserum in the gel, 
but fractionation procedures were specifically omitted in 
order to avoid the risk of exposing serum components 
normally masked beneath the surface structure of HB 
antigen. Should such determinant sites exist and be 
revealed by the manipulations involved in fractionation, 
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the HB antigen would become immobilized in one or other 
of the precipitin reactions in the antiserum-containing 
gel. 
This procedure of immunoabsorbent electrophoresis 
may therefore be regarded as one of immunological 
filtration. It does not depend on the availability of an 
antiserum with mono-specificity to the desired component • 
but rather on an effective polyvalent serum to the 
spectrum of unwanted components in the mixture. 
This technique has a wide application for 
isolating and concentrating abnormal components from 
serologically reacting normal animal or plant fluids. 
It has been used for separation of tobacco mosaic virus 
(TMV) from wild cucumber virus by incorporating one or 
other of the homologous antisera into the gel. Not only 
was separation achieved but the procedure resulted in the 
concentration of TMV and the removal of plant protein from 
the suspension (Polson and Moodie, unpublished data). 
In so far as the experiments with HB antigen in 
human ·serum were concerned the advantages of the method 
were apparent in that with a single antiserum it was 
possible to isolate and purify the HB antigen from a 
mixture of serum proteins which were held back by their 
respective antibodies and entrapped as antigen-antibody 
precipitates in the gel. 
-90-
The isolation of HBAg from this system gave an 
important indication that normal human serum components 





Affinity chromatography may be used to isolate 
either component of a reversibly reacting system. One 
component is coupled to an insoluble matrix and must at 
the same time retain its specific binding capacity. 
Concanavalin A (a plant lectin) by its affinity 
for certain glycoproteins present in HBsAg (Burrell et al., 
1973) will combine reversibly with certain surface 
components of the antigen (Cawley, 1972; Neurath et al., 
1973c). This affinity is not sufficiently specific for 
the purification of HBAg from plasma, since approximately 
15% of serum pro~eins, notably alpha globulins, cerulo-
plasmin, pre-albumin, IgM and IgA immunoglobulins will 
also combine with Concanavalin (Leon, 1967). 
A better system, dependent on the immunological 
specificity of HBAg, either surface or core antigen, 
requires the coupling of the appropriate antibody to an 
insoluble matrix with retention of activity. Provided 
that the antibody is specific, that steric hindrance does 
not occur and that dissociation of the bound substance 
from the ligand can be achieved without damage, then 
adequate yield and purity could be exp ected. 
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Sepharose 4B with its open pore size displays 
virtually all the desirable features of a matrix for the 
preparation of bed materials for affinity chromatography 
(Cautrecasas and Anfinsen, 1971). CNBr-activated 
Sepharose is available commercially, or beaded agarose 
may be activated with CNBr by the method of Porath et al., --
(1967) as modified by Grabow and Prozesky (1973). The 
nature of the reaction product is not known, but it is 
believed that cyanogen bromide reacts with the hydroxyl 
groups of the agarose to form imidocarbonates. These 
groups react during coupling with the amino-groups of the 
ligand to form covalent linkages, probably with multi-
point attachment. 
After reaction between the ligand and the antigen, 
the unbound material is washed away and chaotropic ions 
may be used to reverse the reaction. The covalent linkage 
binding the ligand to the matrix is not affected by this 
procedure and the antigen is eluted leaving the antibody 
attached to the bed. 
METHODS 
One gram of the freeze dried gel (CNBr-activated 
Sepharose 4B, Pharmacia, Fine Chemicals, Uppsala, Sweden) 
was washed for 15 min with 10-
3 M HCl solution over a 
sintered glass filter. The swollen gel (3.5 ml) was 
poured into a small glass column 1.5 cm in diameter and 
14 cm long, fitted at its lower end with a sintered 
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glass filter and closed with a stopcock. The gel was 
washed with 200 ml of coupling buffer (0.1 M carbonate/ 
bicarbonate pH 9.4). 
The procedure required two steps, (i) the coupling 
of the 'antibody' to the matrix and (ii) passing the 
'antigen' through the column . The 'antibody' consisted 
of an antiserum from a baboon 'which had been immunized 
with purified HBs antigen. The 'antigen' was the serum 
from a chronic carrier known to have all three 
morphological forms of the HB antigen present. 
Step (i) .. Two ml of unfractionated baboon antiserum to 
purified HBAg was added to the gel in the column, the 
stopcock was closed and the mixture gently agitated in a 
shaker at room temperature for 2 h. After coupling , the 
column was washed with 0.1 M NaHC0 3 buffer solution 
containing 0.5 M NaCl (200 ml) and reacted with a slow 
flow (40 ml/h) of 1 M ethanolamine pH 8.0 for 2 h. 
Finally the material was washed with 3 cycles of 200 ml 
0.1 M Na acetate buffer containing 1 M NaCl pH 4.0 
followed by 0.1 M borate buffer containing 1 M NaCl 
pH 8.0 and completed with a wash of PBS pH 7.2. 
Step (ii). HB antigen-positive serum of a chronic carrier 
was diluted with PBS 1:10 and 100 ml of this diluted 
serum was allowed to flow through the column at a rate of 
40 ml/h. The column was then washed with 100 ml PBS 
pH 7.2 at the same flow rate. 
Elution was performed with (a) 20 ml of freshly 
-94-
prepared 4 M NaI at a flow rate of lOml/h; (b) 4M NaSCN 
under the same conditions of flow. The eluates from the 
two solutions were kept separately and dialysed 
immediately against running distilled water for 4 h. The 
20 ml of dialysate was freeze dried and re-suspended in 
1.0 ml of PBS pH 7.2. 
The pooled eluates from two consecutive experiments 
were used to immunize a sheep by multiple subcutaneous 
injections on two occasions. The sheep was bled three weeks 
later and the separated serum stored at 4°C. 
Globulin fractions prepared from the serum of the 
immunized sheep were diluted 1:10 for use in the gel of one-
or two-dimensional Laurell electrophoresis plates for 
evaluation of anti-HBAg activity and for the detection of 
any contaminating antibody. 
RESULTS 
Four techniques were used to assess what had been 
achieved by the affinity chromatography: - electron 
microscopy, electrophoresis, immuno-electrophoresis and 
animal inoculation. 
The diluted sample of HBAg-positive donor serum 
after passage through the chromatography column was 







5.1.a. One dimensional Laurel! electrophoresis. 
1% agarose gel contains 1:10 dilution of globulin prepared 
from hyperimmune sheep serum by precipitation with PEG. 
Sheep was immunised with HBAg prepared by affinity 
chromatography using baboon anti-HBs serum. 
Wells 1 - 4 contained log
2 dilutions of HBAg negative 
whole serum. 
Wells 5 - 8 contained similar dilutions of HBAg +ve 
material. Arrow indicates HBsAg precipitin arc. 
PLATE 5 .1. 
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antigen with a similar distribution of the three 
morphological forms of the antigen as that seen in the 
original undiluted serum. There was no apparent greater 
reduction in antigen concentration than could be 
accounted for by the dilution. Examination of the eluate 
after dissociation with sodium iodide revealed the 
presence of small spheres only. Material from ··the 
subsequent dissociation with sodium thio-cyanate showed 
in addition to the small spheres, some filamentous forms 
and occasional Dane particles. The total yield of HBAg 
in the eluates was considerably less than that present 
in diluted serum introduced into the column. 
Electrophoresis in agar gel and immuno-electro-
phoresis with horse anti-human serum however, failed to 
detect the presence of any contaminating proteins in the 
freeze dried concentrates eluted from the chromatography 
column. 
This apparent complete separation of HBAg 
components from human serum components could not be 
sustained when the serum from the sheep immunized with 
the eluates was examined. The globulin fraction from 
this antiserum was evaluated in a series of Laurell,(1965) 
electrophoresis plates and gave the following results: 
When normal human serum in two-fold dilutions was 
migrated by electrophoresis into a gel containing a 1:10 
dilution of the immune sheep globulin, a series of 
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characteristic bullet shaped lines of precipitation 
appeared (Plate 5.1.a., wells 1 - 4), but when the HBAg-
positive serum was treated in the same way (Plate 5.1.a., 
wells 5 - 8) an additional precipitin arc developed 
indicating anti-HBs activity. These antigen-antibody 
reactions were further resolved by two-dimensional 
Laurell electrophoresis (Plates 5.2.a. and b.) wherein 
the HBsAg was clearly responsible for the extra 
precipitin line while the other precipitin lines present 
in both sera corresponded with gammaglobulin and one or 
two components in the region of the alpha and beta 
globulins. The immune globulin was absorbed with 
glutaraldehyde insolubilised normal human serum proteins 
by the method of Ternynck and Avrameas, (1976), to 
produce a monovalent HBsAg specific antiserum (Plate 5. 
2. C. ) 
DISCUSSION 
This method of isolating HBAg from whole serum 
relies on the specificity of the antibody. It is 
theoretically possible to isolate selectively any portion 
of the antigen that has a different and specific immuno-
reactivity. 
In the light of the successful isolation of the 
HBAg from all but trace amounts of two or three serum 
components in the experiments recorded above, several 





5.2.a. 5.2.b. 5.2.c. 
Two dimensional Laurell electrophoresis. Gel of the 
second dimension contains 1:10 dilution of hyperimmune 
sheep globulin (5.2.a. and 5.2.b.1 The gel in 5.2.c. 
contains the identical globulin after absorption with 
insolubi l ised normal human proteins. 
5.2.a. HBAg -ve serum (first dimension). Precipitin 
lines indicate anti-normal human serum activity. 
5.2.b. HBsAg +ve serum (first dimension). Additional 
precipitin line indicates anti-HBs activity. 
5.2.c. HBsAg +ve serum (first dimension). Single 




particle-rich human serum. For these experiments the 
anti-HBc immunoglobulin was purified by PEG 
precipitation from the serum of a chronic carrier whose 
serum had been shown by electron microscopy to be core-
reactive by the formation of core complexes. This 
antibody was coupled to the insoluble matrix. Dane 
particle cores, free of antibody, were prepared by 
detergent treatment of Dane particle-rich serum and 
concentrated by PEG precipitation as described in 
Chapter 3. Eluates from chromatography columns flooded 
with this core antigen were unproductive of anything but 
occasional cores. Some of the reasons for the failure 
of these experiments are discussed below. 
In practice it was important to ensure that high 
ionic strength in the buffer solution should be 
maintained during coupling and washing in order to reduce 
protein to protein adsorption in conditions of low salt 
concentration. This was achieved by adding· 0.5 M NaCl to 
the buffer solutions in the coupling and washing cycles. 
After coupling had been completed, residual active groups 
on the gel could be blocked by adding an excess of a 
small primary amine such as glycine or ethanolamine, and 
in these experiments 1 M ethanolamine was used. After 
the remaining active groups have been blocked, thorough 
washing with alternatively high and low pH buffers is 
recommended, in addition the molarity was kept high and 
1 M NaCl added to the acetate and borate buffers. This 
was necessary for the thorough removal of traces of non-
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covalently adsorbed materials. These adsorbed materials 
were not detected by electrophoretic analysis of the 
eluates. 
The nature of the antigen used in these 
I 
experiments plac~d restrictions on the technique for the 
best results in affinity chromatography. The antigen 
could not be prepared by any method making use of low pH 
conditions or any digestive process before elution. The 
more usual method of washing the attached antigen with 
three cycles of low and high pH buffers had to be omitted 
for this reason. Many workers (Kim and Tilles, 1973; 
Nath et al., 1976 and others) have shown that to prepare 
a monovalent serum it is necessary to dissociate attached 
serum proteins from the surface of the antigen. 
The fact that the eluates injected into the sheep 
gave rise to antibodies to three serum components in 
addition to the HBs antigen after affinity chromatography 
may be explained in one of several ways. The contamin-
ation of the antigen in the eluates by these serum 
components may arise from the donor serum, in which case 
the purification was not complete. The serum components 
may arise from the baboon serum used as the ligand which 
may have been partially eluted from the bed material by 
M~ 
the strong dissociation conditions under 4M SCN. It was 
~ 
shown that the baboon serum reacted in the same manner on 
immuno-electrophoresis as human serum when tested against 
horse anti-human serum. It was thus not possible to 
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differentiate the serum proteins of the two primates by 
this test. 
The third possibility is that the normal serum 
components to which antibodies were formed in the sheep, 
may have been adsorbed to the surface of the HBsAg or 
are perhaps an integral part of it. The latter concept 
is discussed at greater length in Chapter 8. 
-102-
Chapter 6 
DENSITY GRADIENT ZONE ELECTROPHORESIS 
INTRODUCTION 
Zone electrophoresis utilises the movement of a 
charged particle in an electric field. The direction and 
rate of movement in a given system is dependent on the net 
charge on the particle and is proportional to the charge 
density. Proteins, depending on the pH of the system, 
have either a net positive or negative charge. At their 
iso-electric point these charges are equal, resulting in 
a zero migration. Proteins of similar charge will move 
in a fluid medium in similar zones, regardless of size 
differences and proportional to their charge densities. 
This property has been used to separate mixtures of 
proteins, and mixtures of viruses and proteins (reviewed 
by Polson and Russell, 1967). 
Svensson and Valmet, (1955) introduced a zone 
electrophoresis apparatus adapted for use with a density 
gradient in solid supporting media. This was modified 
by Cramer et al., (1957) by using a sucrose density 
gradient, in the study of mouse encephalitis virus. 
Changes in density due to temperature gradients were 
rendered innocuous by the presence of the density 
gradient and convection currents were minimized. 
Polson and Cramer, (1958) further simplified this 
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apparatus. Phenol red was introduced as a marker with 
the sample under investigation because of its high 
electrophoretic mobility. Van Regenmortel, (1960) used 
the symbol R¢ as an index of relative electrophoretic 
mobility expressing the ratio between the distance 
travelled by the test material and the phenol red. The 
ratio R¢ is valid under standard conditions and is 
therefore independent of temperature, concentration of the 
test material or column width. 
The apparatus described by Polson and Cramer, 
(1958) and Polson and Russell, (1967) was used with minor 
modification to study HB antigen containing serum to 
confirm (or otherwise) the degree of electrophoretic 
inhomogeneity of HBsAg reported by Howard and Zuckerman, 
(1973) and to compare the migration index of the antigen 
with that of normal human serum proteins. Millman et al., 
(1970) had demonstrated the formation of a precipitin arc 
by immuno-electrophoresis when human anti-HBs was placed 
in the trough. The position of the antigen was shown in 
relation to the pattern of precipitins developed in a 
similar gel when whole serum was migrated by electro-
phoresis and horse anti-human serum allowed to diffuse 
from the trough. 
Density gradient zone electrophoresis provided a 
method of expanding the electrophoretic pattern of serum 
by the analysis of 20 or more fractions and at the same 
time under standard conditions examining the electro-
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phoretic mobility of (i) HBsAg +ve whole serum 
(ii) partially purified HBsAg prepared from whole serum 
by differential ultracentrifugation, and (iii) Mucasol 
treated partially purified HBsAg. 
METHODS 
Antigen 
HBsAg was demonstrated in the serum by electron 
microscopy. The samples of partially purified HBsAg were 
obtained by sedimenting 2.0 ml of whole serum at 60 000 x 
g for 90 min. The pellet was resuspended in 2.0 ml of 
the buffer or in 2.0 ml of 2% Mucasol in the buffer. 
These samples were held at 4°C for 5 days before use. 
Apparatus 
The apparatus is depicted in Fig. 6.1. and consists 
of an upright column (B) diameter 2.5 cm, with a vertical 
side limb (C) and stopcock (F). The upper ends of the 
columns were connected by a right angled tube to the 
buffer reservoirs (D) and (E). The lower end of the 
column (B) was provided with a side vent (A) and was 
sealed into a length of thick glass capillary tubing (G). 
The capillary tubing was connected to a length of rubber 
tubing of appropriate diameter equipped with clamp (H). 
Finally this rubber tubing was connected to the lower 
exit from a pair of mixing Ehrlenmeyer flasks connected 
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in series. The flow between the flasks was controlled by 
capillary tubing (J) and clamp (K). 
Procedure 
1. Veronal buffer 0.05 M, pH 8.6 was slowly added to 
the apparatus using the upper end of the column (B). It 
was important that no bubbles were formed while the 
pouring of the buffer was in process. To achieve this 
and to ensure that no air bubbles were left in contact 
with the glass walls of the apparatus, the tubes were 
cleaned meticulously beforehand, using a detergent, and 
removing all traces of this detergent to avoid its effect 
on the antigen. 
2. A 40% solution of sucrose in veronal buffer was 
allowed to flow into the apparatus through side vent (A) 
until the level in the vertical limb was at X. 
3. Buffer was added to the column (B) from above 
until the sucrose solution had been displaced downwards 
to about 2.0 cm above the capillary tube. This displaced 
the sucrose solution upwards about as far as the stopcock 
of the vertical limb on the right-hand side. 
4. The stopcock was closed. 
5. A little of the 40% sucrose was run out of the 
column through the capillary tubing (G), in order to 
sharpen the top edge of the sucrose boundary and to bring 
it level with the top of the capillary tube. 
6. The mixing flasks were now connected, the higher 
flask containing 170 ml of 40% sucrose and the lower 160 ml 
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of plain buffer and a magnetic stirrer. The lower flask 
was sealed with a rubber bung and the lead to the column 
was milked to remove any air bubbles. 
7. The clamp (K) between the flasks was removed and 
the magnetic stirrer started. 
8. The tap at (H) was opened to allow the sucrose 
gradient to flow very gently into the column. In this 
fashion a gradient of increasing density of sucrose, 
was formed, displacing the buffer upwards as it extended. 
9. The gradient was run until about 20 ml of sucrose 
were left in the flask. 
10. Approximately 5 ml of the lower part of the 
gradient was run off the column through the capillary (G) 
to ensure a concentration of about 35 %. 
11. The sample was then dissolved in 35 % sucrose and 
the density adjusted to ensure that a drop of the sample 
sedimented in 35% sucrose and floated on 40% sucrose. 
12. 2 ml of the sample, to which a pinch of phenol red 
was added, was slowly introduced through capillary (G). 
The sample had a density of approximately 37% sucrose and 
as the most dense lower part of the gradient was about 
35%, the 40% sucrose formed a shelf on which the sample 
was based. These sharp density shelves prevented mixing. 
13. Reversible silver electrodes (Polson and Russell, 
1967) were used in the electrode vessels and immersed in 
a band of saturated NaCl in the buffer. 
14. The large stopcock in the apparatus was opened 
gently and the sample balanced by removal of buffer from 
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the top of the capillary tube. 
15. Cold air from a fan was directed onto the apparatus 
to minimize heating. 
16. The apparatus was allowed to stand for two hours 
to allow diffusion to establish a continuous gradient 
through the sample layer. 
17. A voltage gradient of 3 - 4V/cm was applied which 
in these conditions resulted in a flow of 20 m amp which 
was maintained for 20 h. 
18. At the completion of the experiment fractions were 
taken from the capillary tube at the base of the column, 
each sample measuring approximately 1 ml. 
19. Each fraction was tested for HBsAg by counter 
current electrophoresis (CEP) in agarose gel with baboon 
anti-HBs in the anodic well. Those fractions which were 
positive for HBsAg by CEP were examined electron 
microscopically. Each fraction was subjected to electro-
phoresis in agarose gel. 
RESULTS 
The electrophoretograms of the fractions of HB 
antigen-containing whole serum, taken from the density 
gradient zone electrophoresis column are presented in 
Plate 6.1. A control normal serum was included with 
each batch of analyses for reference. In the earlier 
fractions the gamma globulins are seen to be clearly 
separated from the faster migrating components and from 
the albumin. 
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Each fraction was examined also by counter 
electrophoresis for the presence of HBsAg. It will be 
seen that the antigen was detectable in fractions No. 8 
through to No. 14 indicating a considerable measure of 
electrophoretic inhomogeneity and that it was associated 
with the alpha and beta globulins. Using the mid-point of 
the antigen-positive zone for comparison with the 
migration of phenol red the R¢ value was calculated to 
be, 0.40. 
Two other preparations were examined under 
identical experimental conditions. HBAg prepared from 
the same serum (se.e above) by differential ultra-
centrifugation, with the final sedimented pellet suspended 
either in i. buffer (Veronal 0.05 M, pH 8.6) or in ii. 
2% Mucasol in the same buffer at pH 8.6. 
Analysis of the fractions from the zone electro-
phoresis column of these two preparations of antigen 
revealed important differences. Electrophoreses were 
less informative than before because of the marked 
reduction in serum proteins following centrifugation of 
the antigen. Counter electrophoresis of each fraction 
against anti-HBs (Fig. 6.2.) showed, as expected, that 
there was no difference in the electrophoretic mobility 
of the HB antigen and a similar R¢ value of 0.39 was 
obtained. The inhomogeneity was less since the antigen 
was confined to fractions Nos. 10, 11 and 12. The Mucasol 
treated antigen however had acquired an increased 
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electrophoretic mobility with a significantly higher 
R¢ value of, 0.55. 
Lastly, the fractions giving positive results 
in the counter electrophoresis tests were examined by 
electron microscopy. The original whole serum was found 
to contain large numbers of all three morphological forms 
with occasional small complexes of Dane particles. No 
alteration in the distribution of the morphological forms 
of the HBAg was found in the electrophoretic fractions 
except that the Dane particle complexes were seen only in 
the slowest migrating fractions of the antigen-positive 
zone. 
DISCUSSION 
The results indicated that HBAg is inhomogeneous in 
migration in an electrical field in a sucrose density 
gradient. The heterogeneity under these conditions is 
dependent on charge density differences. The migration of 
antigen in this system, either in whole serum or as 
prepared from whole serum by ultracentrifugation was 
constant when expressed as a ratio of the migration of 
phenol red. Thus the presence of whole serum components 
did not influence the R¢ of the antigen. Gel electro-
phoresis of the antigen-positive fractions fr9m the zone 
electrophoresis column showed that this apparatus did not 
separate HBAg from serum components even when considerable 
increase in the span of the apparatus was considered. 
-112-
This is in contrast to the report of Howard and Zuckerman, 
(1973) who were able to purify small spherical antigen 
from partially fractionated HBsAg positive serum by 
electrofocusing in a pH gradient formed by a mixture of 
carrier ampholytes. 
The alteration in R¢ for detergent treated antigen 
indicated that the charge density had been increased to 
give a greater net anionic charge. This alteration by 
the detergent may be due to the removal of lipoprotein 
or to other less negatively charged (slowly migrating) 
proteins from the outer layer of the HBsAg or to the 
reduction of the ratio of the amino to carboxyl groups 
of the exposed protein. It is shown elsewhere in this 
thesis that detergent treated antigen retains its 
immunological identity indicating that severe disruption 
of the exposed protein determinant groups was unlikely. 
On the other hand it was also shown (see later) that 
detergent treatment exteriorises immunoglobulins but this 
might be expected to slow the migration of the antigen. 
This is also suggested by the behaviour of naturally 
occurring complexed HBsAg untreated serum, as these 
complexes were only found amongst the slowest migrating 
HBsAg fractions. The presence of gamma globulin in the 
complexes reduces the net negative charge and so exposure 
of IgG was not responsible for the increased R¢ value 
obtained after detergent treatment. 
Other workers (Burrell, 1975; Neurath et al., (1974) 
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have shown the presence of several normal serum proteins 
associated with the surface antigen after partial 
purification by methods which have been shown to be 
damaging (Stannard and Moodie, 1976). In the series 
produced by Neurath et al., (1974) the largest category 
of serum components found in association with the antigen 
was that of the apo-l~poprotein group of substances. 
These would be detergent labile and their removal would 
allow the higher charged proteins such as albumin (also 
shown to be present) to increase the net negative charge 
on the surface of the HBAg particle and so produce a 
faster migration with a correspondingly high R¢ value. 
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Chapter 7 
IMMUNE ELECTRON MICROSCOPY 
INTRODUCTION 
The advantage of immune electron microscopy over 
conventional methods of detecting immunological reactions 
lies with the direct visualisation of the immune complex. 
It is generally thought that assays involving radioactive 
techniques have a higher sensitivity for detecting immune 
reactions, but immune electron microscopy, where the 
antigen is of sufficient size to allow easy detection, 
although perhaps lacking this extreme sensitivity has the 
unique advantage of absolute specificity. In most of the 
instances quoted in this work, the technique was used for 
the demonstration of antibody to "morphological" sub-
groups (as opposed to serological subgroups) of the HB 
antigen and was at times the only method for obtaining 
information of this reaction; it frequently circumvented 
the necessity of full-scale purification of the subgroups. 
Almeida et al., (1971) was the first to use this 
technique in the field of hepatitis B antigen analysis 
to demonstrate the separate specificity of the Dane core. 
It was only some years later that Hoofnagle et al., (1973) 
were able to confirm this observation by complement 
fixation. (see Chapter 3. Discussion). 
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Immune electron microscopy was used as a 
sophisticated technique for immunological reactions 
involving the antigens of hepatitis B virus associated 
components and their respective antibodies. 
METHODS 
Antigen i. I:-IBsAg in human serum concentrated by ultra-
centrifugation 
ii. I:-IBcAg produced from i. (above) and released 
by treatment with 1% Mucasol or 0.025% deoxycholate 
and iii. I:-IBcAg extracted from liver cell nuclei of a 
patient with fulminating fatal hepatitis. 
Antibodies 
Immune serum from a baboon inoculated with purified 
HBsAg (Natal Institute of Immunology, 129 Princes Street, 
Durban) and human sera containing anti-I:-IBs or anti-HBc or 
both. Sera from chronic carriers were also used as a 
source of anti-HBIII. 
One "grid dose" of antigen comprising all morph-
ological components was resuspended in 0.25 ml PBS after 
concentration and washing by ultra-centrifugation. An 
equal volume of the appropriate antibody preparation was 
added and the mixture dispersed by immediate inversion of 
the centrifuge tube. Incubation at 37°C for 1 h was 
followed by overnight storage at 4°C. A control sample 
utilising the same antigen but incubated with PBS instead 
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of antiserum was included. The mixtures were then 
centrifuged at SO 000 x g for 60 min to sediment the 
antigen, and washed with phosphate buffer by two further 
cycles of the same force and duration before negative 
staining for examination in the microscope. 
RESULTS 
Antigen Control (HBsAg) 
Hepatitis B antigen suspended in PBS (Plate ~.l.a.) 
showed the three components, spheres, · tubules and Dane 
particles scattered at random and without attached 
immunoglobulin filaments. 
Antibody to HB Surface Antigen (anti-HBs) 
Appropriate dilutions of specific animal antisera 
from baboons or sheep, or of human sera containing 
antibody to the surface of hepatitis B antigen, when 
incubated with HBsAg produced immune complexes such as 
those represented in the micrograph (Plate 7.1.b.). 
Optimal concentrations of the reactants were demonstrated 
by the involvement of virtually all the particles of 
surface antigen present in the sample and by the cross-
linking of the antigen by strands of immunoglobulin to 
form moderately sized discrete immune complexes. A 
preparation of antigen, but treated with 1% Mucasol in 
PBS (to strip the Dane cores of their coats) prior to 
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7.1.a. HBsAg control. Prepared from serum by differential ultra-
centrifugation and incubated in PBS. Magnification x 120 000 
7.1.b. HBsAg aggregated into immune complexes by incubation with 
baboon anti-HBs. Fluffy appearance is due to excess of antibody. 
Magnification x 120 000 
PLATE 7.1. 
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incubation with antiserum (Plate 7.2.a.) showed the 
characteristic "moth eaten" appearance of the particles. 
When anti-HBs was added to this preparation the filaments, 
spherical particles and Dane coats were similarly 
complexed (Plate 7.2.b.) and therefore aggregation was 
unaffected by the detergent treatment. Occasional free 
lying Dane core particles could be found with no evidence 
of attached gamma globulin. 
Antibody to HB Core Antigen (anti-HBc) 
Antigen, pretreated with 1% Mucasol detergent, was 
incubated with an appropriate dilution of globulin 
containing anti-HBc obtained from a chronic carrier of 
HBsAg. 
The electron micrographs (Plate 7.3.a. and b.) 
showed the presence of aggregates of Dane core particles, 
linked by immunoglobulin strands, with associated Dane 
coats but with unaggregated evenly distributed filaments 
and small spheres of surface antigen present in the 
preparation. The surface antigen showed the moth eaten 
appearance due to the effect of Mucasol treatment. 
It is apparent that not all of the inner core 
particles have been completely released from the Dane 
coats which are present in varying degrees of disruption 
in the complexes. Where antigen was treated first with 
proteolytic enzyme followed by exposure to the detergent 
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7.2.a. Mucasol control. Partially purified HBsAg treated with 1% 
Mucasol in PBS. Magnification x 120 000 
7.2.b. Mucasol treated HBsAg aggrega~ed by baboon anti-HBs. 
Magnification x 80 000 
PLATE 7.2. 
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7.3.a. Mucasol treated HBsAg incubated with globulin prepared from 
a chronic HBsAg carrier. Two HBcAg complexes are shown. Dane coats 
are seen within the complexes. Filamentous and small spherical 
HBsAg are unaggregated. Magnification x 80 000 
7.3.b. A similar preparation to 7.3.a. Magnification x 200 000 
PLATE 7.3. 
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and then subjected to anti-HBc, large complexes consisting 
entirely of core particles linked together by immuno-
globulin were seen (Plates 7.4.a. and b.) without Dane 
particle coats. 
Exactly similar core complexes were seen when the 
same antibody was added to a suspension of Dane cores 
extracted from the nuclei of hepatic cells of a renal 
dialysis patient on immunosuppression. 
Antibody to a Cryptic Antigen (anti-HB111 ) 
Untreated serum from a chronic carrier frequently 
showed the presence of Dane particle complexes in which 
there were also 'tadpoles' consisting of Dane particles 
with attached tails of surface antigen and free tubular 
filaments as well (Plate 7.5.) 
When the antigen was treated with a detergent, e.g. 
Mucasol or deoxycholate, and then mixed with serum from 
a chronic carrier, in this case the patient's own serum, 
damaged Dane particles (cores and coats) were found in 
large aggregates (Plates 7.3.a. and b.) 
When antigen was treated first with protease 
0.6 units/ml followed by detergent treatment and 
incubated with carrier globulin, large complexes of 
Dane cores occurred (Plates 7.4.a. and b.), but no 
Dane coats were present in the complexes. 
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7.4.a. and b. HBsAg treated with protease followed by Mucasol prior 
to incubation with globulin from the same serum. Two HBc complexes 
are shown (cf. Plate 7.3.). Dane coats are not involved in the immune 
complexes , Magnification x 120 000 
PLATE 7.4. 
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7.5. Untreated serum from HBAg positive blood donors. Dane 
particle complexes, including tadpole forms, demonstrate the 








The demonstration by electron microscopy of an 
antigen-antibody reaction between the small spherical 
antigen, filaments and intact Dane particles (HBsAg) 
and specific antiserum (anti-HBs) is direct evidence of 
reaction which may be monitored by many serological 
techniques. 
Hoofnagle et al., (1973) demonstrated antibody to 
the core of the Dane particle in all sera from chronic 
carriers. Serum from an immune blood donor, fractionated 
into IgG and IgM classes of antibody and incubated with 
a suitable core preparation demonstrated anti-HBc 
activity by immune electron microscopy (Stannard~ al., 
1973). 
A preparation of Dane cores, prepared from liver 
cell nuclei or from circulating antigen by detergent 
release, was standardised to achieve near optimal 
proportions before deciding from the electron micrograph 
on the specificity of the reaction. Conditions of 
antibody excess produced . small complexes, and occasional 
isolated cores, but in each case the cores were smothered 
by irnrnunoglobulin strands. Antigen excess was somewhat 
misleading since core complexes were rarely present and 
the presence of anti-HBc on single cores could only be 
assessed by visually identifying attached immunoglobulin 
molecules. This required optimal resolution of the 
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specimen, a condition which was produced only with great 
technical difficulty and after painstaking preparative 
procedures. The zone of equivalence was shown by the 
formation of discrete complexes, the involvement of 
virtually all the specific antigenic structures in these 
complexes and the linkage of these structures by 
discrete antibody molecules. Once the appropriate 
dilution of antiserum has been determined in relation to 
the standardised quantity of antigen, the reaction was 
assessed for specificity. Minor medifications were 
introduced when determining the effect of detergents or 
enzymes but such variations of procedure wpre monitored 
by comparison with a control preparation adjusted for 
optimal proportions. 
The presence of the third antigen-antibody system 
(anti-HB 111 ) was suggested by the occurrence in sera of 
circulating Dane complexes (Field and Cossart, 1971; 
Z:alanet al., 1971; Stannard et~., 1973). It was 
further noted that treatment by detergent (1% Mucasol) 
or bile salt (0.25% deoxycholate) of antigen in the 
presence of antibody globulins from the sera of chronic 
carriers, produced very large aggregates of Dane 
particles. Closer examination of these aggregates 
showed that three Dane particle components, i.e. 
damaged but whole Dane particles, partially attached 
coats and separated coats, were all involved in this 
complex. In addition there were "tadpoles" consisting 
of Dane particles with attached tails of surface antigen 
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the globulins from the same serum were the result of at 
least two antibodies, anti-HBc and anti-HB 111 . These 
formed combined aggregates with Dane particles linked 
by antibody to partially detached coats and to intact 
but unmasked coats. Partially released cores, still 
held by the coats, were in turn seen to be linked to 
detached cores and the whole mass interlocked into a 
single aggregate. (Plates 7.3.a. and b.). This would 
explain the occurrence of mixed aggregates in a system 
where separate specificities and antibodies should 
result in pure aggregates of each component. Further 
information in keeping with the hypothesis was obtained 
by examining the effect of a proteolytic enzyme, 
protease, on the mixed aggregates. 
Protease digestion of partially purified antigen 
had no apparent effect on the morphology or antigenicity 
of the Dane coat. However, if protease was allowed to 
digest partially purified antigen under the same 
conditions, the aggregates produced after detergent 
treatment by incubation with homologous globulin did not 
contain Dane coats. Only detached cores were involved 
in the antibody reaction as shown by the presence of 
radially attached strands of globulin (Plates 7.4.a. and 
b.). Protease digestion must be considered to have 
altered or removed the determinant sites for anti-HBIII 
in the Dane coat wall, but the sites on the cores for 
anti-HBc determination remained unaltered. Neurath et 
al., (1976) detected determinant sites on damaged Dane 
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and "free tails" or tubular filaments of surface antigen 
but no small spheres (Plate 7.5.). It was thought that 
an antigenic site, located in the Dane coat material and 
the "tails", was revealed by the action of these agents. 
Damaged HBsAg of the small spherical form do not possess 
this cryptic antigen since these components remain 
unaggregated after detergent treatment and after 
exposure to the serum of chronic carriers. 
The cryptic "HB 111 antigen" of the Dane co
at may 
be unmasked during the life of the Dane particle in the 
circulation, allowing reaction with anti-HB 111 , and 
accounting for the presence of naturally occurring 
circulating small complexes of Dane particles. These 
were often seen in sera which contained D~ne particles, 
but in each case the majority of the Danes were intact 
and unaggregated, the small numbers of aggregated part-
icles are thought to represent a minority population 
n e a ring the end o f the i r " 1 i f e s p an" . I n the in vi tr o 
studies using partially purified (globulin-free) large 
component antigen, it was possible to treat the antige~ 
with various agents and then return the patient's own 
immunoglqbulin to assess his antibody response. It was 
found that lipid ~amage by brief chloroform extraction, 
anionic detergents (Tween 80 and Mucasol) and bile salts 
unmasked the cryptic antigen. The resultant damage also 
released the core from the coat which in turn initiated 
HbcAg/anti-HBc reaction. The complexes formed by 
detergent treated antigen followed by incubation with 
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particles, "tadpoles" and tubules using affinity 
chromatography and the "e" system. These authors 
suggested that these sites may be similar to those 
described (Moodie et al., 1974) in relation to 
anti-HB111 . 
It may therefore be stated that the simple 
observation of an immunological reaction by electron 
microscopy resulted in the identification of reactive 
sites of the hepatitis B antigen without dependence on 
the isolation and purification of the antigenic sub-
units. The occurrence of antibody in chronic carrier 
serum directed against a cryptic antigen present in 
Dane particles from the same patient may be of value in 
underst anding and unravelling the complexities of this 
peculiar system of antigens and antibodies. 
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Chapter 8 
SERUM PROTEINS AND HB ANTIGEN 
INTRODUCTION 
Purification of the hepatitis B antigen for 
analysis of protein and lipid components has been achieved 
by a variety of methods (Gerin et al., 1969; Millman et al., 
1970; Dreesman et~., 1972, and many others) However 
these procedures have seldom been controlled by electron 
microscopy and have often utilised preparative methods 
that may well have caused unexpected, undetected and 
unintentional alteration of the surface of the antigen. 
These changes are particularly difficult to assess when 
some surface components appear to be normal constituents 
of human plasma. The extent of purification necessary to 
produce an HBsAg mono-specific antiserum (Boenisch and 
Katz, 1971), free from antibody cross reacting with normal 
serum components, may suggest that normal serum proteins 
are indeed present on the surface of the antigen in an 
association which may be part of its normal structure or 
consequent upon absorption. Certainly, HBsAg isolated 
from serum by a mono-specific antiserum in an affinity 
chromatograph column and inoculated into a sheep, produced 
an antiserum with antibodies to both HBsAg and to several 
normal serum components (Chapter 5). Two communications 
(Neurath et al., 1974; Burrell, 1975) reported the 
presence of human plasma proteins associated with HBsAg. 
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Neurath et al., (1974), using affinity chromatography, 
reported binding of HBsAg, as assayed by RIA, by anti-
bodies to a variety of serum components and concluded that 
these antigenic determinants were an integral part of 
HBsAg. Burrell, (1975) using purified 125!-labelled 
HBsAg, showed that HBAg particles have tightly bound 
antigenic determinants to a variety of serum proteins but 
was uncertain whether these were actually integrated into 
the structure of the HBAg particles. These observations 
were a little at variance with the early report of Millman 
et al., (1971) who, using the relatively insensitive 
technique of gel diffusion, failed to detect ~ny reaction 
between purified antigen and antibody to serum components, 
but was able to demonstrate precipitin lines under the 
same conditions when the HBAg was treated with 1% Tween 
80. This suggested that if the serum proteins were 
present as an integral part of the antigen, they were non-
reactive unless first unmasked by the action of the 
detergent. However, this was not confirmed in the 
reports by Burrell, (1975) and Neurath et al., (1974) 
both of which claimed serum protein determinant sites on 
antigen not treated with detergent. Burrell did, however, 
report a loss of antigen after purification in 28% 
caesium chloride and for this reason used a gradient of 
sucrose in 14.3% caesium chloride. Neurath and his co-
workers, on the other hand, prepared antigen by a 
procedure which included the use of a 10 - 50% glycerol 
gradient operative for 15.5 h. 
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Immune electron microscopy was chosen as the method 
for examining the effects of the serological reaction. 
Preliminary experiments showed that anti-human IgG could 
be used to identify IgG anti-HBs on the surface of 
hepatitis B antigen particles when used in a sandwich 
technique. The experiments, outlined below, were designed 
with a two-fold objective; to determine whether serum 
proteins were present on the surface of undamaged 
components of HBAg, and if not, whether treatment with 
detergent or glycerol or caesium chloride under the 
conditions empl9yed by Burrell, (1975) and Neurath et al., 
(1974) could unmask any serum protein. 
METHODS 
HBAg was prepared for this series of experiments by 
sedimentation of a pellet from whole serum at 60 000 x g 
for 60 min resuspended in 0.06 M phosphate buffer, pH 
7. 2. 
Experiment I 
One "grid dose" of antigen in 0.25 ml of phosphate 
buffer was incubated with an equal volume of either 
(i) 1/20 dilution of goat anti-human gamma-specific IgG; 
or (ii) PBS, for 30 min at 37°C and thereafter prepared 
for electron microscopy by sedimentation and twice 
washing with phosphate buffer at SO 000 x g for 60 min. 
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Experiment II 
"Grid doses" of antigen were suspended in 
(i) PBS 
or (ii) 1% Mucasol 
or (iii) 15% caesium chloride 
or (iv) 25% glycerol 
and held at 4°C for 18 h. The antigen was sedimented at 
60 000 x g for 60 min and resuspended in each case in 
0.25 ml PBS and incubated with appropriate dilution (see 
Chapter 7) of anti-human IgG immunoglobulin. The antigen 
was washed by 2 cycles of centrifugation in phosphate 
buffer at 50 000 x g for 1 h before negative-staining with 




Hepatitis B antigen, sedimented from whole serum . 
and incubated with anti-human IgG, was dispersed and 
uncomplexed and was identical in appearance with the 
control preparation in PBS shown in Chapter 7 (Plate 7.1.aJ 
Experiment II 
Detergent treated antigen showed the observed 
distortions of the HBAg components ascribed to this agent 
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(Chapter 7), but antigen treated with caesium chloride 
and glycerol showed no visible morphological changes. 
After incubation with anti-IgG, the untreated antigen 
(PBS incubated) again showed no evidence of complex 
formation. In sharp contrast with this, however, the 
detergent treated antigen was strikingly complexed by 
anti-IgG with involvement of spheres, filaments and Dane 
coats (Plate 8.1.a.). No free cores were seen in the 
complexes. HBAg particles which had been exposed to 
glycerol and caesium chloride were also obviously 
complexed by the anti-IgG (Plate 8.1.b.). 
Elaboration of these experiments for further 
evidence of receptors on the HBsAg was undertaken with 
highly specific antisera, e.g. anti-albumJn, anti-IgG 
(Fab), anti-IgG (Fe), anti-IgM (mu-chain specific) and 
anti-C 3. All these antisera complexed the treated 
antigen. All with the exception of anti-albumen and 
one source of anti-C 3 , failed to tomplex undamaged 
antigen. 
DISCUSSION 
These results indicate that anti-IgG immuno-
globulin doe.s not form comp1exes with undamaged antigen. 
Antigen prepared by simple centrifugation cannot be 
considered to be absolutely pure. If IgG is present as 
a surface contaminant of the partially purified antigen, 
this was not detected by the methods used in these 
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8.1.a. Mucasol treated antigen incubated with anti-human IgG. A 
large immune complex consisting of Dane coats, filamentous antigen 
and small spheres. Magnification x 80 000 
8.1.b. Caesium chloride treated antigen incubated with anti-human 
IgG. A large immune complex consisting almost entirely of Dane 




On the contrary, the same antigen, after mild 
disruptive treatment, was firmly complexed by anti-IgG. 
Using anti-IgG as a marker, HBAg prepared from stored 
whole serum by centrifugation, has a receptor site for 
anti-human IgG, a site which is only unmasked by 
disruptive treatments. This receptor site is an 
integral part of the structure of the HBsAg and however 
masked, is sufficiently integrated with the antigen 
itself to res1st dislocation or loss by moderately harsh 
treatment. The work of Burrell, (1975) and Neurath et 
al., (1974) remains valid concerning the affinity of 
various antisera to human proteins fo.r HBAg, but the 
present experiments now appear to dismiss any suggestion 
that these serum components are not integral to the 
structure of the antigen. The technique of immune 
microscopy enables the reaction between receptor site and 
antiserum to be made at a morphological level. 
The detection of cross-reacting sites to these 
human proteins corresponds well with the proteins 
· detected on HBAg by Millman, Neurath and Burrell, (1975). 
Albumin was found in the experiments in this study to be 
present on the surface of the untreated antigen and 
persisted after detergent treatment. 
The antigen used in the tests was stored at 4°C for 
a period varying between 2 months and 4 years and in this 
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respect, therefore, differs from naturally circulating 
antigen. It is possible that the conditions of storage 
were responsible for changes in the antigen to render 
sites inaccessible to antisera, and that this masking is 
removed by the methods described. However, evidence for 
the presence of irnmunoglobulin components and activated 
complement determinants "within" the morphological 




ENZYME AND DETERGENT EFFECT ON HB ANTIGEN 
INTRODUCTION 
Until a decade ago the distinction between serum 
hepatitis and infectious hepatitis was made by 
consideration of the route of infection. This inferred 
that hepatitis B was transmitted entirely parenterally. 
Evidence that non-parenteral spread occurred in closed 
populations and between intimate contacts is presented 
in Chapter 1.2. The significance of these findings high-
lighted the search for antigen in the faeces and in all 
secretions such as tears, urine, bile, intestinal 
secretions, menstrual fluid and saliva. 
Using standard serological tests for the detection 
of HB antigen Grob and Jemelka, (1971) reported positive 
results in faecal extracts from all of eleven patients 
with acute hepatitis. Cossart and Vahrman, (1970) were 
unable to find HB antigen in faecal extracts from 
patients with acute hepatitis after 100-fold concentration 
of the extracts, and Gust et al., (1970) reported 47 
negative results from 15 patients with antigenaemia. 
More recently Irwin~~., (1975) were unable to confirm 
the presence of HBAg in the faeces of 11 patients with 
acute hepatitis B or in any of 8 carriers. 
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At the upper end of the alimentary canal two reports 
(Serpeau ~al., 1971; Akdamar et al., 1971) indicated 
that hepatitis B antigen could be detected, again by 
serological methods, in bile but not in gastric or 
duodenal secretions. This, although no such inference was 
drawn by the authors, seemed to suggest that HBAg present 
in bile, was no longer detectable when the bile-containing-
antigen was excreted into the duodenal juice. 
It is possible that dilution of the bile lowered 
the concentration of antigen to below the threshold of 
detection but other possibilities exist. The reports of 
Piazza et al., (1973) and Grabow and Prozesky, (1973) 
indicate the presence of an inhibitory factor in the 
gastro-intestinal tract. Both of these groups independ-
ently found that if HBAg was incubated with faecal extracts 
at 37°C, the previously detectable antigen no longer gave 
positive results in their indicator systems. The 
inhibition did not occur if the temperature of the 
incubation was 2 - 4°C. In addition Piazza et al., (1973) 
found that human small bowel mucosa similarly inhibited 
the demonstration of hepatitis B antigen. Gastric juice 
had no effect on the detection of antigen but acholic 
faeces had the same effect as normal faeces. 
From these reports it appeared that an enzyme (or 
enzymes) could be responsible for the disappearance of 
serologically reactive antigen, particularly as the 
reaction was stated to be temperature dependent. 
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Hirschman et al., (1973) described the morphological 
effect of enzyme on preparations of HBAg but other workers 
found the antigen to be resistant to digestion by a wide 
variety of enzymes (Rao and Vyas, 1974). 
This conflicting evidence, together ,with an 
awareness of the two major an ti gens of the Dane parti1cle, 
prompted the performance of a series of experiments 
designed to test the opposing concepts by the construction 
of an in vitro model of the gastro-intestinal tract. 
METHODS 
In each of the following experiments the antigen 
used was produced as follows: Sucrose 5% was added to 
2.0 ml of the 10% re-precipitate fraction produced by PEG 
displacement. (Fig. 2.1.c.). This was chromatographed on 
a Sepharose 4B column (20 x 2.5 cm) at a flow rate of 
12.5 ml per h. The eluate was monitored by u-v absorption 
at 280 nm and the initial 5.0 ml corresponding to the 
first peak after the void volume was collected (Fig.3.1.c.). 
This fraction was centrifuged at 60 000 x g for 90 min and 
the antigen was resuspended in the enzyme or reagent as 
stated in the various experiments. 
Experiment 1 
(i) The antigen was resuspended in 2.0 ml bile. 
The bile was obtained from a post-cholecystectomy I-tube 
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and was shown to be free of hepatitis B antigen by 
electron microscopy. 
The mixture was kept at 4°C overnight. 
(ii) The antigen was resuspended in Na deoxycholate 
O.S% w/v H2o cc 23H39o 2 .cooNa Hopkins and Williams, 
Chadwell Heath, Essex, England) and kept at 4°C overnight. 
(iii) The antigen was resuspended in protease 0.6 
units/ml H2o (Streptomyces griseus, Sigma) and incubated 
at 37°C for one h. 
(iv) The antigen was resuspended in 2.0 ml of a 
faecal extract, divided into 2 samples of which one was 
incubated at 37°C for 1 hand the other at 37°C for 18 h. 
The faecal extract was prepared by emulsifying 10 g of 
fresh faecal material in 10 ml PBS. This suspension was 
clarified by cycles of low speed centrifugation and a 
final cycle of SO 000 x g for 60 min produced a clear 
yellow supernatant fluid for use as a faecal extract. 
In each case after the relevant treatment, the 
mixture was centrifuged at SO 000 x g for 60 min and the 
pellet washed by centrifugation twice before examination 
by electron microscopy. 
Experiment 2 
Deoxycholate-treated-antigen, obtained from the 
procedure described in Experiment 1 (ii), was digested 
with protease under the following conditions: 
(i) The deoxycholate-treated-antigen was washed by 
centrifugation at SO 000 x g for 60 min, suspended in 
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2.0 ml of distilled water containing 12 units of protease 
and incubated at 37°C for one h. A control preparation 
in which deoxycholate-treated-antigen was incubated in 
2.0 ml distilled water without protease, was included. 
(ii) To unwashed deoxycholate-treated-antigen, 12 
units of protease was added and the mixture was incubated 
at 4°C for 1 h. A control specimen without protease was 
included in the experiment. 
(iii) Preparations identical with those in (ii) 
above were incubated at 37°C for one h. 
To samples in which core particles were sought, a 
further step was included. The centrifuged antigen was 
resuspended in 0.25 ml PBS to which 0.25 ml of anti-HBc 
globulin was added. This was incubated for 1 hat 37°C 
and for 19 hat 4°C. The final preparation was prepared 




produced by the method of Experiment 2 (iii) above. 
Faecal-extract-treated-antigen was produced by the method 
of Experiment 1 (iv). A control specimen in which PBS 
was used instead of the deoxycholate and protease was 
included. 
These two samples were centrifuged, washed and 
finally suspended in 0.3 ml PBS. One dimensional rocket 
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Laurell immuno-electrophoresis was performed in a 1% 
agarose gel in which baboon anti-HBs was incorporated. 
RESULTS 
Experiment 1 
Partial purification of the antigen by PEG 
precipitation and Sepharose chromatography produced a 
fraction in which the antigen was removed from the 
majority of the serum components and in particular from 
the IgG anti-HBc. This combination of methods resulted in 
a supply of antigen~ which although not pure, was 
considered adequate for determining the effect of bile or 
bile salts and enzymes on both the surface antigen and the 
inner core and the outer coat of the Dane particle. 
(Chapter 4). 
On electron microscopy both bile and deoxycholate-
treated-antigen showed a similar "detergent effect". 
(Plate 9.1.). The small spherical antigen had rarefied 
centres, the filamentous forms were segmented and no 
intact Dane particles were seen. The Dane particles were 
seen in various stages of uncoating due to the "detergent 
effect". Characteristically those most easily found on 
the screen occurred in small collections in close 
proximity to one another as a result of the "detergent 
effect" on circulating Dane complexes. There were no 
antibody molecules linking the Dane cores. This confirmed 
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Globulin free HBsAg after Na deoxychlate treatment. Small spheres are 
rarefied and penetrated by stain. Some filaments are seen to be 
segmented and appear to break into small spheres. Most Dane particles 
are penetrated by stain, some have released central cores. Small groups 
of Dane particles indicate the effect of detergent on circulating Dane 
complexes. No antibody molecules are attached to released Dane cores. 
Magnification x 100 000 
PLATE 9.1. 
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the removal of the IgG anti-HBc and the absence, in this 
carrier serum, of anti-HBc IgM activity. 
Digestion by protease at 37°C for 1 h had no 
visible effect on the antigen as assessed by the 
unaltered morphology on electron microscopy. 
Faecal-extract-treated-antigen showed "detergent 
effect" and free cores could be demonstrated by the 
addition of anti-HBc. The antigen after incubation at 
37°C for 18 h showed considerably more damage and few 
filamentous forms were seen. An occasional damaged Dane 
particle could be detected. 
Experiment 2 
The deoxycholate-treated-antigen which had been 
washed free of the bile salts when incubated at 37°C for 
1 .h with protease did not differ in morphology from the 
control to which no protease had been added. Both samples 
showed the "detergent effect" of the bile salt as 
described in Experiment 1 above, but no additional 
changes were seen in the sample which had been digested 
with protease. This was in sharp contrast to the action 
of protease in the presence of deoxycholate. Mixtures 
incubated at 37°C for 1 h showed that no intact surface 
antigen remained; the spheres, filaments and Dane 
particle coats had largely disappeared or were morpholog-
ically unrecognizable as antigen. An occasional Dane core 
-145-
was found among the debris. The addition of core 
antibody to such a sample resulted in the formation of 
complexes of these scattered Dane cores, and small 
aggregates of 7 - 11 cores linked by visible antibody 
molecules were more easily seen. (Plate 9.2.b.). A few 
intact small spheres were present after incubation with 
the anti-HBc, but these spheres did not show any 
"detergent effect", thus indicating that this antigen 
represented HBsAg present in the anti-HBc prepared from 
carrier serum. 
Experiment 3 
No precipitin line was formed in the gel by the 
deoxycholate-and-protease-treated-antigen. The faecal-
extract-antigen and the control specimen produced the 
usual rocked shaped precipitate in one dimensional 
Laurell immuno-electrophoresis. 
DISCUSSION 
Bile and sodium deoxycholate have a similar effect 
on the antigen. Once this was established the single bile 
salt was used in subsequent experiments. Many trial 
digestions were performed and examined. Those outlined 
above were representative of key points in the 
development of the "in vitro" model of the intestinal 
tract. 
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9.2.a. Detergent treated HBsAg-containing serum. Released Dane 
cores with radially attached antibody. HBsAg shows mild 
detergent effect. Magnification x 120 000 
9.2.b. Partially purified HBsAg following protease digestion in 
the presence of deoxycholate. Anti-HBc added to form immune 
complexes from scattered free cores. HBsAg no longer present 
(cf.9.2.a.). Magnification x 120 000 
PLATE 9.2. 
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It may be assumed that antigen present in the gall 
bladder and hepatic ducts, whether actively secreted with 
the bile or released into the bile space as a result of 
cell lysis, will be subject to detergent effect. This 
effect was absolutely predictable whether bile, sodium 
deoxycholate or Mucasol was used and has been reported 
with other detergents such as Nonidet P 40 and Tween 80 
(Almeida et al., 1971). 
The detergent-treated-antigen was found to react 
with anti-HBs both in gel-precipitin systems and on 
immune electron microscopy. Reports of the detection of 
antigen in bile or duodenal juice immediately after 
induced contraction of the gall bladder are easily 
understood since under these conditions antigen is 
exposed to the detergent effect of the bile alone. 
Protease (not a single enzyme) was used as a 
representative of the bacterial enzymes present in the 
bowel. It was felt that these, rather than the secretory 
digestive enzymes, were more likely to be the enzymes 
present in active form in faecal material and it was this 
that was twice reported as having an inhibitory effect 
on the detection of antigen (Piazza et al., 1973; 
Grabow and Prozesky, 1973). 
Protease alone had no visible effect on the 
antigen, nor did digestion by protease of detergent 
damaged antigen after washing away the detergent; but 
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protease in the presence of the bile salt virtually 
destroyed all of the surface antigen. No reactive 
soluble antigen was demonstrated in an adequately 
controlled one dimensional Laurell electrophoresis. 
Simple faecal extracts of various origins were 
applied to the HB antigen and in every instance the antigen 
showed the detergent effect. Enzyme activity in the small 
and large intestine occurs in the presence of bile salts 
(detergent) yet there was no apparent loss of surface 
antigen by quantitative Laurel! electrophoresis. This is 
at variance with published reports (Piazza et al., 1973; 
Grabow and Prozesky, 1973) of faecal inhibitors, but the 
demonstration of the efficiency of a single bile salt and 
bacterial enzyme in destroying the surface antigen was 
felt to indicate adequately that surface antigen could 
not survive passage from the duodenum through the 
intestinal tract. It is possible that antigen may leak 
into the lumen with small haemorrhages in the lower bowel, 
particularly if raised portal pressure due to liver damage 
is present. The relatively brief exposure of this 
antigen to the intestinal contents would allow the antigen 
to remain reactive to serological identification. 
The Dane core was found to survive under these 
experimental conditions and to retain its antigenic 
identity in immune electron microscopy. Recently Grabow 
et al., (1975) stated that they were no longer able to 
detect these cores after prolonged digestion with their 
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enzyme preparation. 
Hepatitis B surface antigen thus does not survive 
enzymatic digestion in the presence of a detergent and 
except for added blood components, it is presumed that 




From the start it was appreciated that a ready 
supply of hepatitis B antigen was an inescapable pre-
requisite. Human plasma was the obvious starting material 
but since the Dane particle (Dane et al., 1970) had 
acquired a notoriety as a possible candidate for the title 
of hepatitis B virus, it was essential also to have a 
convenient supply of Dane particles. This was the first 
and the most difficult problem. 
Dane particles could be demonstrated in 30% of 
plasma from local chronic carriers but in most instances 
they represented only a small proportion of the total 
hepatitis B antigen. So it was necessary to find a way of 
separating and concentrating the various components of 
HBAg. 
Of particular interest was the important source of 
Dane core particles from the liver cell nuclei of a 
patient dying of acute fulminating hepatitis B. Such 
material was made available for diagnostic purposes in 
the early days of the investigation. The sample consisted 
of 3 - 4 g of liver tissue, which was homogenized and 
shown to have a high concentration of Dane core particles 
with practically no detectable surface antigen. Regret-
fully the rest of this post mortem liver was incinerated 
before it could be possessed. 
-151-
It was presumed that another post mortem ltver 
source of Dane core particles would soon appear, but 
unfortunately no further material of this nature appeared 
during the 4 years of this research study. This meant in 
effect that Dane core particles would have to be 
fractionated and concentrated from the plasma of chronic 
carriers. 
Tissue sources other than the liver proved to be un-
rewarding. 
All efforts were thereafter confined to plasma 
units from chronic carriers kindly sent to the laboratory 
from the Western Province Blood Transfusion Service. 
Some donors contributed more than one donation for this 
research programme. 
The use of polyethylene glycol for concentrating 
and selectively precipitating hepatitis B antigen from 
serum became a routine procedure when quantities of HBAg 
larger than grid doses were required. Antigen produced 
by displacement and antigen sedimented directly from 
plasma by ultracentrifugation were morphologically and 
serologically indistinguishable. This was in contrast 
with the behaviour and appearance of HBAg after exposure 
to low pH, detergent or caesium chloride. Apart from the 
convenient concentration in one fraction of those 
components of plasma that were under investigation (all 
the large component antigen and all the gamma globulins), 
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precipitation with polyethylene glycol was occasionally 
the only method by which HBAg could be recovered from 
dilute solutions without concentration of salts and small 
molecular weight proteins. The failure to isolate HBAg 
completely from serum proteins or to achieve a greater 
degree of morphological separation of the components of 
HBAg by this independently developed technique, must be 
judged by comparing it with the results of the techniques 
used by Johnson and Newman (1972); Neurath et al., (1973)a 
and Nath et ~-, (1976). Thes·e workers, using differing 
conditions of pH and ionic strength, confirmed the 
preliminary nature of this preparative procedure. De Rizzo 
et al., (1972) following the method of Polson et al., (1964) 
used 8% PEG 6 000 at pH 4.6 to precipitate HBAg together 
with the alpha-globulins, (fibrinogen) and a minor 
proportion of albumin and gamma globulins. This step was 
followed by 3 cycles of absorption, washing and elution 
of the HBAg onto and from polyelectrolyte 60 to give a 
preparation suitable for application to more sophisticated 
purification techniques. The HBAg produced by this 
efficient large scale method ietained serological activi~y, 
but no morphological studies were reported. Evidence 
presented in this thesis would suggest that considerable 
damage to large components of the antigen would result 
from the low pH PEG precipitation. 
The use of PEG in this work at a safe pH with 
diluted serum, and the adoption of a reprecipitation step, 
was found to give exactly reproducible results when 
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assessed by the distribution of serum proteins 
(Plate 2.1.a.) 
The second requirement for preparing Dane particle 
antigen called for removal of coexisting antibody from the 
preparation. The considerations which were given priority 
when choosing techniques, were the avoidance of any harsh 
process detrimental to the antigen and the ability to use 
the method for large scale processing. These were felt to 
be essential if sufficient antigenic material was to be 
prepared for serological techniques in use at the time. 
The basic methods of sedimenting and chromatographing 
concentrated fractions were usefully employed for immune 
electron microscopy; the development of batch ion-exchange 
method satisfactorily separated large amounts of antigen 
from globulin. When the final antigen fraction (Plate 
3.2.a.7.) was treated with Mucasol, not only were antibody 
free Dane cores produced but electrophoresis in agarose gel 
demonstrated total absence of the residual S-lipoprotein 
component. 
There are many methods of isolating relatively 
small amounts of HBAg, but the large scale ion-exchange 
batch method developed in this study proved to be neither 
totally destructive of the large components (row pH) nor 
apparently damaging to the surface antigen (caesium 
chloride, glycerol). 
The relative inability to attain a clear cut 
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separation between Dane particles · and filamentous antigen, 
and small spherical particles, by PEG displacement, even 
when small increments were used, indicates that a factor 
additional to Stokes radius was operative. Similarly 
sized particles with identical surface charge densities 
should be excluded by a single concentration of the 
polymer. The presence . of small spheres in the fractions 
precipitated by a low concentration of PEG indicated that 
these particles must differ from their soluble companions. 
The difference was shown not to be one of size. Reports 
on the heterogeneity of purified HBAg in electrophoretic 
migration (Kim and Tilles, 1973) and the extensive 
analysis of the charge differencis by Howard and Zuckerman, 
(1973) of small spheres of significantly similar diameter 
confirmed that this was indeed the reason. This was 
proved by Howard and Zuckerman, (1973) by electrofocussing 
HBAg in a gradient of carrier ampholytes a process which 
resulted in the isolation of pure HBAg from a partially 
purified (gel filtration) fraction. 
Zone electrophoresis of serum in the apparatus of 
Polson and Russell, (1967) confirmed the alpha 2-beta 
globulin migration of HBAg, and indicated that separation 
of the antigen from serum proteins by gradient electro-
phoresis could only be achieved by electrofocussing with 
the aid of an ampholyte gradient. The detection of immune 
complexes in the most slowly migrating HBAg positive 
fractions has also been recorded with Allerton virus 
(Polson and Kipps, 1966). 
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The specially designed preparative immunoabsorbent 
technique (H-tube) was used initially to isolate HBAg from 
a partially purified PEG fraction (Moodie and Polson, 1973). 
It was subsequently found that whole serum could be 
applied to the column to achieve a one-step isolation 
procedure. Recent work on plant viruses indicates that the 
effect of hysteresis can be abolished by isolating the 
reaction gel from the wall of tube by suspension in a 
hydrophobic mixture of organic solvents. The important 
potential of the system for isolating abnormal components 
from normal human fluids or secretions has not yet been 
fully assessed. 
The ability of sheep to react strongly to a large 
antigenic molecule such as lipoprotein and IgM (Harboe 
and Inglid, 1973) determined the choice of this species 
for raising an antiserum to HBsAg. The purification 
procedure for obtaining HBsAg was deliberately tailored to 
avoid alteration of its morphological and immunological 
properties. Antigen purified by affinity chromatography 
with baboon anti-HBs and free from contaminant human 
serum proteins when assessed by immuno-electrophoresis, 
nevertheless produced antibody against several human 
proteins when used to immunize a sheep. Rather than 
indicting the procedure for this "impurity", it would 
appear that active disruptive treatment is necessary for 
the detachment of closely associated serum proteins from 
the surface of serologically reacting HBsAg. Many 
reports of inoculation of "purified" HBAg into rabbits, 
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(Melartin and Blumberg, 1966) mice, (Millman et al., 
19 70a) guinea pigs, (Purcell et al., 1970) horses, (Cabasso 
et al., 1971) and sheep, (Duimel et al., 1972) relate that 
the majority of antisera produced required absorption with 
normal human serum proteins (NHS). Indeed one ingenious 
method was developed to overcome this difficulty by 
inducing tolerance to NHS before immunization with 
partially purified HBsAg (Madalinski et al., 1971). 
Dreesman et ~., (1972) investigated three preparative 
methods, including low pH dissociation and ultrasonication, 
for isolating pure HBsAg. Each method produced an HBsAg 
which, when inoculated into goats, raised an antiserum 
with anti-NHS activity. Some of these antisera were 
acceptable for use as a monospecific reagent after 
dilution, but others required absorption with NHS. Maupas 
et al., (1976) found that the eluate from an anti-HBs-
cyanogen-bromide-activated Sepharose column contained 
residual NHS components. These were removed by passage of 
the eluate over an immunoabsorbent coated with anti-NHS 
antibodies. This product was treated with formalin and 
used as a vaccine in chimpanzees and humans. 
Normal human serum components in trace amounts in 
a vaccine for primate use are probably not important and 
affinity chromatography yields a preparation of adequate 
purity for this purpose. 
Study of the morphological and serological effect 
of bile and faecal extract on HBAg, and the use of 
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deoxycholate and a bacterial enzyme (protease) as 
representatives of some of the digestive processes 
encountered in the intestinal tract, was prompted by 
conflicting reports of detection of HBAg in faeces. 
These experiments suggested that HBsAg was totally 
destroyed by these agents (Moodie et al., 1974a) and that 
the possible infectivity of faeces would be judged by 
detection of Dane core particles. No such particles 
could be demonstrated in faecal samples and Grabow et al., 
(1975) demonstrated the disappearance of Dane core 
particles after exposure to a different set of bacterial 
enzymes (carboxypeptidase). 
In spite of the increasing frequency of electron 
microscopic examination of faeces for hepati~is A antigen 
and for infectious viral diarrhoea agents (rot~viruses) 
there have been no further reports, (as far as is known) 
of faecal HBAg. 
Immune electron microscopy was extensively employed 
in assessing the antigenic specificity of the cryptic 
antigen of the Dane coat and in detecting anti-human 
serum receptors on the surface antigen. The technique of 
immune electron microscopy is well established and reports 
in other fields (such as hepatitis A) indicate the 
acceptance of this method. The demonstration of natur-
ally occurring Dane complexes (Stannard et al., 1973) and 
the monitoring of the development of methods for the 
artificial reproduction of this reaction were performed 
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by electron microscopy. Artificial exposure of the 
cryptic antigenic site on the Dane coat resulted in a 
reaction with an antibody present in the serum of a 
chronic carrier (Moodie et~., 1974). This system is 
felt to be operative in all hepatitis B infections as an 
expression of the host response to degraded Dane and 
"tadpole" particles. Neurath et al., (1976) have con-
vincingly demonstrated by immune electron microscopy that 
antibody toe-antigen, when incubated with Dane particle 
containing HBAg, complexes Dane coats and filamentous 
forms of the antigen. This is at variance with the 
suggestion of Nielsen et al., (1974) that e-antigen is 
related to the core component of the Dane particle. It is 
also startlingly different from the characterization of 
e-antigen as a small soluble protein (Magnius, 1975). 
The recent brief communication (Neurath and Strick, 1977) 
indicating that e-antigen may be an antibody will 
reconcile these two views~ 
The implications of this recent letter have not b~~n 
assessed in this work, but investigation of the cryptic 
antigen (HB 111 ) as a receptor site f
ore-antigen would 
clarfiy the suggestion of Neurath et al., (1976) that the 
HBIII and e-systems are related. 
Of equal clinical significance is the demonstration 
of IgG components within the surface of the HBsAg 
(Stannard and Moodie, 1976). This investigation has been 
extended. to show that both Fab and Fe fractions of IgG, 
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IgM and c3 are exposed by detergent treatment of HBAg 
prepared from stored serum. An earlier paper by 
Madalinski et al. , (19 7 4) described the absorption of 
partially purified heat treated (80°C for 1 h) HBAg to 
DEAE-cellulose at high pH. IgG, IgA and IgM were eluted 
from this preparation by a salt and pH gradient. These 
eluted antibodies were shown to be specific for HBsAg by 
precipitin reactions in gels. No c3 was detected in the 
eluate. 
The electron microscopic findings described in this 
work confirm that after some minor degree of damage, immuno-
globulin determinants may be identified in close association 
with the HBAg; in addition c3 was identified in this 
situation. It is felt that this gives some support to an 
hypothesis of continuous production of anti-HBs by the host 
under conditions of antigen excess. This reduced humoral 
response results in a stable association between these 
components and HBsAg. An association which in active 
hepatitis and in the chronic carrier, is unable to 
saturate HBsAg determinant sites or to cross link the 
majority of particles. A shift in balance towards 
recovery ' is heralded by circulating immune complexes and 
finally by clearance of the complexes from the circulation 
and elimination of infected hepatocytes. 
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